Preliminary information on Stockmann’s revenue and operating profit in 2017

STOCKMANN plc, Inside Information 11.1.2018 at 16:30 EET According to preliminary financial information, the Stockmann Group’s revenue was approximately EUR 315 million in the fourth quarter of 2017. Revenue in comparable businesses* was on a par with the previous year. Lindex’s revenue in comparable stores was down by 1% in the quarter. Stockmann Retail’s fourth-quarter revenue was on a par with the previous year in comparable businesses. The Group’s revenue for the full year 2017 amounted to approximately EUR 1 056 million, down by 1% in comparable businesses. The Stockmann Group’s operating profit for 2017 will not reach the profit guidance published on 26 September 2017. According to preliminary information, adjusted operating profit in continuing operations in 2017 will be approximately EUR 12 million (2016: EUR 30.9 million). Lindex’s adjusted operating profit is estimated to be approximately EUR 13 million (2016: EUR 54.9 million), which is significantly lower than in the previous year. The gross margin in Lindex operations has remained on a low level, and cost savings with its profitability improvement programme will be reached only in 2018. Both Stockmann Retail and Real Estate divisions will improve their operating results in 2017, compared to the previous year. However, costs in Stockmann’s operations were also higher than targeted in the fourth quarter. Figures are based on unaudited preliminary financial information in continuing operations. Previous guidance for 2017 (published on 26 September 2017)Stockmann expects the Group’s revenue for 2017 to decline due to weaker sales development of Lindex, and changes in the store network and product mix. Adjusted operating profit in continuing operations is expected to be approximately on a par with or slightly weaker than in 2016. Stockmann will publish its financial statements bulletin on 14 February 2018. *Revenue in comparable businesses refers to revenue excluding divested and closed units, i.e. Stockmann Delicatessen in Finland, Hobby Hall, Oulu department store, and Lindex stores in Russia. Further information:Kai Laitinen, CFO, tel. +358 9 121 5800 www.stockmanngroup.com  STOCKMANN plcLauri VeijalainenCEO Distribution:Nasdaq HelsinkiPrincipal media

SaltX secures additional 15 MSEK funding for accelerating the market introduction of HeatBoost in Europe

As recently communicated SaltX, has already been awarded  20 MSEK for this project by the European Commission and its H2020 program. "With this additional funding, we will be able to speed up the time to market as we can allocate even more resources and mitigate project risks. SaltX gas heat pump technology improves energy efficiency at reasonable cost, and will be a disruptive alternative to conventional gas boilers”, says Karl Bohman, CEO of SaltX Technology. SaltX is now working with several major gas utilities and boiler manufacturers to implement a robust and cost-effective product that can meet the new efficiency requirements and be timely rolled out on the European market. SaltX addresses a global market for HeatBoost worth 3.5 billion Euros. The funding is subject to the due diligence of InnoEnergy and final agreements. For further information, please contact:Karl Bohman, CEO SaltX Technology, tel: +46-705 600 268 ************************************************** SaltX Technology is obliged to disclose this information under the EU Market Abuse Regulation. The information was provided by the contact person listed above, for publication on January 11, 2018 at 17.00 CET. About InnoEnergyInnoEnergy - http://www.innoenergy.com - is a European company that finances and actively supports the integration of education, technology, business and entrepreneurship and strengthening the culture of innovation. Its strategic objective is to become the leading engine of innovation in the field of sustainable energy.   InnoEnergy has financed some 320+ project with over 170 million Euros. About HeatBoostSaltX Gas Heat Pump concept – HeatBoost – has the potential to increase the energy efficiency by up to 40 percent compared to today’s conventional gas boilers, saving typical European households up to 500 Euros per year in natural gas expenses. The system will to be priced at a premium to conventional gas boilers, achieving a payback time of less than two years. About SaltXSaltX Technology develops and sells patented energy storage technology, which is marketed under the brand SaltX ™. Customers consist mainly of major global OEM partners such as Alfa Laval, Mobile Climate Control and Rheem. SaltX Technology's stock is listed on Nasdaq Stockholm First North. FNCA Sweden AB is SaltX Technology’s Certified Adviser. For more information, visit www.saltxtechnology.com. Stockholm2018-01-11

Growth in Qt Group Plc’s net sales for 2017 falls slightly below earlier estimate

Based on the preliminary figures before auditing, the company’s net sales in 2017 amounted to EUR 36.2 million, with 11.8 per cent growth from the previous year. In Q4/2017, the company’s net sales amounted to EUR 10.1 million, with 14.0 per cent growth from the previous year. At comparable exchange rates, the company’s net sales grew by 20.3 per cent in Q4/2017 and 13.3 per cent in 2017. In the company’s view, the slightly slower growth or its reasons will not affect the company’s outlook for the future. There might be significant differences between quarters and comparison periods in the growth of net sales also in the future, depending on the timing of individual contracts. The company still estimates the growth prospects for its business in the next few years as very promising and keeps its long-term strategy and goals unaltered. The company’s financial goals are still to achieve, in 2021, annual net sales of EUR 100 million and an operating margin (EBIT-%) of more than 15 percent. The company estimates the growth of its net sales to pick up speed in 2018 with over 15 per cent growth from the previous year. Due to investments in line with our growth strategy, the company’s operating result will, in line with earlier estimates, show a substantial loss also in 2018. The forecast does not take the effects of changes in exchange rates into consideration. The company will release its financial statements bulletin and financial statements for 2017 on Friday 16 February 2018 at 8:00 a.m. Helsinki, 11 January 2018Qt Group PlcBoard of Directors For more information, please contact:Juha Varelius, CEO, tel. +358 9 8861 8040 DISTRIBUTIONNASDAQ HelsinkiKey media Qt Group Plc is responsible for Qt development, productization and licensing under commercial and open source licenses. The Qt offering includes a development environment that enables the reuse of software code across numerous different operating systems, platforms and screen types, ranging from desktops and embedded systems to wearables and mobile devices. Qt is used by approximately 1 million developers worldwide and is the leading independent technology behind millions of devices and applications. Qt is the platform of choice for in-vehicle systems, industrial automation devices and other business critical applications manufacturers, and is used by leading global players in 70+ industries. The Qt Company operates in China, Finland, Germany, Japan, Korea, Norway, Russia and USA with about 200 employees worldwide. The Qt Group is headquartered in Espoo, Finland and is listed on Nasdaq Helsinki Stock Exchange. The company’s net sales in year 2016 was 32.4 MEUR.To learn more visit http://qt.io

Preliminary results for Edgeware Q4 2017

The calculated EBIT for the fourth quarter will amount to about SEK 6 million (10), which means a full year calculated EBIT of about SEK 12 million (19). The gross margin for the quarter amounted to about 74 %. These preliminary numbers are not yet audited. “Based on experience from previous years’ seasonality and revenue split between the quarters, the fourth quarter has not developed in the way we had expected, explains Joachim Roos, CEO of Edgeware. We have seen lower spending levels among some of our largest customers compared to forecasts. In addition, year-end budget flushes have been lower than previous years.  We have been successful in growing our business in APAC, but sales have been below expectations in parts of AMERICAS and lower than last year in EMEA. We need to analyse how we sell into the different markets and take action to ensure that our investments in sales capacity will have positive effects. Our products are competitive and the newly developed features and additions to the company’s portfolio are well received by existing and new customers.  We continue to have a strong belief in the underlying growth of the TV and video market. We remain confident that we can capture this market growth. Our competitive edge is strong and our gross margins healthy.”  The full fourth quarter and full year report for 2017 will be published on February 12, which is a few days earlier than previously announced.  Edgeware will host a telephone conference tomorrow, January 12 at 10.00 CET with CEO Joachim Roos and CFO Steeve Fuhr answering questions regarding the preliminary results. Link to the webcast: https://tv.streamfabriken.com/2018-01-12-press-conference Participant dial in numbers:SE: +46856642662 UK +442030089801US: +18557532235 This is information that Edgeware AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 20.000 CET on 11 January 2018.

Publishing of YIT Corporation's Financial Statements Bulletin 2017 on February 1, 2018

YIT Corporation's Financial Statements Bulletin for 2017 will be published on Thursday, February 1, 2018 at approximately 8:00 a.m. Finnish time (EET, approx. 06:00 a.m. GMT). The stock exchange release and the presentation materials in Finnish and in English will be published at that time on the company's website at www.yitgroup.com/investors.  News conference for investors and media  YIT will arrange a news conference on Thursday, February 1, 2018 at 11:00 a.m. Finnish time (EET, at 9:00 a.m. GMT) at YIT's head office, Panuntie 11, 00620 Helsinki, Finland. The event is in English and targeted for analysts, portfolio managers and the media. Welcome!  Webcast  The news conference and presentation by the President and CEO of YIT Corporation Kari Kauniskangas can also be followed through a live webcast at www.yitgroup.com/webcast. The live webcast starts at 11:00 a.m. (EET) and a recording of the webcast will be available at approximately 1:00 p.m (EET) at the same address.  Conference call  The news conference can be participated also through a conference call. Conference call participants are requested to dial in at least five minutes prior to the start of the conference, at 10:55 a.m. (EET). Conference call numbers are: Participants from UK and outside of Nordic countries +44 (0)330 336 9105 Participants from Sweden +46 (0)8 5033 6574 Participants from Norway +47 2100 2610 The participants will be asked to provide the following confirmation code: 5413651  During the webcast and conference call, all questions should be presented in English. At the end of the event, the media has the opportunity to ask questions also in Finnish. Questions can be also posted via the chat feature of the live webcast. Annual Report and Financial Statements Annual Report 2017 including the Financial Statements will be published during week 8/2018, at the latest. For further information, please contact:   Hanna Jaakkola, Vice President, Investor Relations, YIT Corporation, tel. +358 40 5666 070, hanna.jaakkola@yit.fi   YIT CORPORATION   Hanna JaakkolaVice President, Investor Relations   Distribution: NASDAQ OMX, principal media, www.yitgroup.com   YIT creates better living environment by developing and constructing housing, business premises, infrastructure and entire areas. Our vision is to bring more life in sustainable cities. We want to focus on caring for customer, visionary urban development, passionate execution and inspiring leadership. Our growth engine is urban development involving partners. Our operating area covers Finland, Russia, the Baltic countries, the Czech Republic, Slovakia and Poland. In 2016, our revenue amounted to nearly EUR 1.8 billion, and we employ about 5,300 employees. Our share is listed on Nasdaq Helsinki. www.yitgroup.com 

Italian metals industrial consulting firm Danieli strengthens their cyberdefense using Clavister

Örnsköldsvik, Sweden. January 12, 2018. Clavister (CLAV: NASDAQ), a leader in high-performance network security solutions, has concluded a SEK 1.7M deal with Italian metals industrial consultancy Danieli through Clavister partner Eyelink. The upgrade of their security infrastructure to the latest models from Clavister makes it more modern and resilient as well as higher performing, helping them combat modern cyber threats that ensure business continuity. The new solution based on Clavister’s latest Next Generation Firewall Appliances offers excellent performance combined with a wide range of security and connectivity features, allowing Danieli to consolidate their infrastructure on fewer hardware models. “Danieli continues to be one of our valued customers after more than 10 years of cooperation, especially in terms of accessing and purchasing professional services which gives them the full value of Clavister’s solutions,” explains Nicola Fort, CEO of Eyelink. “They appreciate the rock solid platform that Clavister offers, managing not only the security aspects, but also ensuring excellent connectivity and traffic control with highest possible performance,” Fort explains why Danieli chose Clavister products. Additionally, the flexible integration with other network equipment and open standards are other factors that Danieli find attractive. “This renewed trust and confidence in Clavister is a good example of how great partners are helping world class companies to protect themselves against cyber threats with our highly innovative solutions. That Eyelink retains the customer satisfaction by utilizing Clavister year after year is exactly the kind of feedback we love to see,” says Andreas Åsander, Vice President of Global Enterprise Sales.  

Genetic analysis can improve depression therapy

Pharmaceutical treatment of depression commonly makes use of selective serotonin reuptake inhibitors (SSRIs) of which escitalopram is the most frequently administered clinically. However, escitalopram therapy is currently limited by the fact that some patients do not respond well to the drug, while others develop adverse reactions requiring discontinuation of treatment. In order to individualise drug therapy, researchers are attempting to establish genetic biomarkers that can predict an individual’s response to drugs. In a recent study, it was discovered that variation in the gene encoding the enzyme responsible for escitalopram metabolism (CYP2C19) is very important in this respect. Individuals with a variant of the gene promoting increased enzyme expression had blood levels of escitalopram too low to impact the depression symptoms, whereas patients with a defective CYP2C19 gene reached drug levels which were too high. Overall, one third of the 2,087 study participants achieved escitalopram blood levels that were either too high or too low. Interestingly, the researchers found that 30 per cent of the patients carrying gene variants causing excessive or inadequate enzyme levels switched to other drugs within one year, in contrast with only 10 to 12 per cent of patients carrying the common gene. “Our study shows that genotyping of CYP2C19 could be of considerable clinical value in individualising doses of escitalopram so that a better all-round antidepressive effect could be achieved for the patients,” says Professor Magnus Ingelman-Sundberg at Karolinska Institutet’s Department of Physiology and Pharmacology who led the study together with Professor Espen Molden. “Because CYP2C19 is involved in the metabolism of many different SSRIs, the finding is also applicable to other types of antidepressants.”  The study was financed with grants from the Swedish Brain Fund, the Swedish Research Council and Horizon 2020 (the EU framework programme for research and innovation). Co-author Espen Molden has declared a fee from the company Lundbeck for running psychopharmacology courses for doctors; the other authors have reported no commercial interests.   Publication: “Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients”. Marin M. Jukic, Tore Haslemo, Espen Molden, Magnus Ingelman-Sundberg. The American Journal of Psychiatry, online 12 January 2018, doi: 10.1176/appi.ajp.2017.17050550.

Nordea’s Fourth Quarter and Full Year Results 2017 will be presented on Thursday 25 January 2018

The report will be published at approximately 07.00 CET. Press conferenceTime: 09.00 CET. Registration opens at 08.30.For security reasons, a valid identity card is required. Venue: Smålandsgatan 17, Stockholm.Casper von Koskull, President and Group CEO, will present the results.The presentation will be conducted in English and can be viewed live (direct link).  You will also find the presentation material at www.nordea.com/ir.To attend the press conference please contact: Afroditi Kellberg at Nordea via e-mail afroditi.kellberg@nordea.comTo listen in to the press conference (starting at 09:00) and participate in the following Q&A session (starting at approximately 09.30 with Torsten Hagen Jørgensen, Group COO and Deputy CEO, and Rodney Alfvén, Head of Investor Relations) please dial +44(0)330 336 9105 or +46(0)8 5033 6574, confirmation code 9764098, no later than 08.50 CET.  After the conference an indexed on-demand replay will be available here.  A replay will also be available until 1 February by dialling +44 (0)207 660 0134 or +46 (0)8 5199 3077, access code 9764098. Analyst and investor presentation in London on 31 January Time: 15.00 local time. Venue: UBS, 5 Broadgate, London, EC2M 2QSTorsten Hagen Jørgensen, Group COO and Deputy CEO, and Pawel Wyszynski, Senior IR Officer, will participate. The presentation, including Q&A, is expected to last approximately one hour.To attend please contact: Kate Reece at UBS via e-mail kate.reece@ubs.com.The report will be published in English and Swedish. A press release with a summary of the results will be published in English, Swedish, Danish, Finnish and Norwegian.For further information:Rodney Alfvén, Head of Investor Relations, +46 72 235 05 15Claes Eliasson, Acting Head of Group External Communications, +46 72 141 67 12

NCC to construct Dansmästaren project including 133 rental units in Uppsala

“Uppsala is expanding at a rapid rate and there is still substantial demand for rental units. With NCC as a partner, we will be able to add a number of much-needed rental units in a new city district,” says Niosha Baghaei, Construction Manager, Uppsalahem AB. Dansmästaren will be have a strategically important location at the northern entrance of the new Rosendal district. The district will be close to transport links and particularly, the university campus area, which is also likely to be reflected in the people who will live, work and study in the area. “It is exciting to now start work on the project in Rosendal, which is also our first to be conducted in a partnering format. It is entirely aligned with our owner directives of adding new parking facilities in prime strategic locations throughout the city,” says Gustav Törnquist, Construction and Property Manager, Uppsala Parkerings AB. Dansmästaren will consist of a six-story building with 133 rental apartments ranging from studio to one-bedroom apartments and adapted for student living. The apartments will be built to meet a Silver environmental rating from the Sweden Green Building Council. The parking facility will cover an area of nearly 14,500 square meters and featureabout 460 parking spaces, of which 100 will be equipped with charge points for electric cars. The ground floor will house a large 2,200-square-meter premises. “This is a challenging and exciting project being conducted in partnering form together with Uppsalahem and Uppsala Parkerings AB. Partnering is based on close and transparent dialogue between all of the parties involved throughout the duration of the project, which guarantees the implementation process and ensures a high-quality and sustainable end-product,” says Henrik Landelius, Head of NCC Building Sweden. Work is expected to commence in February with occupancy scheduled for summer 2020. The transaction will be registered among orders in the fourth quarter of 2017 in the NCC Building business area.

SenzaGen’s final validation report of GARDskin™ submitted to regulatory authorities – reveals highest test prediction accuracy in the field

The analysis of the data has been performed by an independent validation statistics consultant, according to the regulatory requirements. This analysis is the base for the official report now sent in to ECVAM. The data shows that the mean accuracy from all three independent laboratories (Eurofins BioPharma Product Testing in Germany, Burleson's Research Technologies in the United States and SenzaGen's own laboratory in Lund) is very high, reaching an accuracy of 93,8%.  The validation has included a large number of coded chemicals unknown to the validation laboratories, to enable the blinded testing demanded in this process. All laboratory results have been provided in a blinded manner to an external validating statistics consultant, who has now decoded the identity of the chemicals to compare the GARD classification performed at each lab, and analysed the prediction accuracy of GARD in classifying compounds as non-sensitizers or sensitizers. The validation report also includes data on the robustness of the test platform and its transferability. The results in this report constitutes the basis for the evaluation of SenzaGen's tests in the ECVAM Scientific Committee and within the OECD for regulatory approval and Test Guideline recommendation on the use of GARDskin. The regulatory decision from OECD is expected in April 2019. GARDpotency™, which is based on the same biological platform, is being validated in parallel with GARDskin™, and is thus expected to be approved and recommended at the same time. “These excellent validation results underpin the potential for GARD testing to become a game changer in in vitro allergy testing. We have long been aware of its high performance, and the validation now also provided by independent laboratories is of course very satisfying. Importantly, the validation has highlighted the simplicity of assay transfers to other labs. This adds to the confidence of further laboratories around the world to set up our unique assay,” says Anki Malmborg Hager, CEO of SenzaGen. A comprehensive report of the results will be presented at the Society of Toxicology’s 57th Annual Meeting 11-15 March in San Antonio, US. For more information: Anki Malmborg Hager, CEO, SenzaGen ABEmail: anki.malmborg.hager@senzagen.com Telephone: +46 768 284822 About GARD GARD is a group of tests for assessing chemical skin sensitizers. The tests make use of genetic biomarkers for more than 200 genes which cover the entire immune reaction and are relevant to predicting the risk of hypersensitivity. The tests have up to 90% reliability. This compares with the current predominant test method, experiments on mice, which has an accuracy of 70-75%. SenzaGen's tests are also capable of measuring the potency of a substance's allergenic properties. Consequently, GARD tests provide a much more comprehensive basis for determining whether a substance should be classified as an allergen than current testing methods. About SenzaGen SenzaGen makes it possible to replace animal experiments with in vitro genetic testing to determine the allergenicity of the chemicals we come into contact with in our daily lives, such as for example in cosmetics, pharmaceuticals, food products and dyes. The company's patented tests are the most reliable on the market and provide more information than traditional evaluation methods. We ourselves sell the tests in Sweden and the USA, and we sell through partners in several other countries. Over the next few years the company will expand geographically, make alliances with more distribution partners and launch further unique tests. SenzaGen has its headquarters in Lund in Sweden and a subsidiary in San Francisco, USA. For more information visit www.senzagen.com The information was provided by the contact person for publication on 12 January 2018 at 08:45. SenzaGen AB are listed on Nasdaq First North in Stockholm and FNCA is the company’s Certified Adviser. For more information, please visit www.senzagen.com

CombiGene and Cell and Gene Therapy Catapult sign agreement to develop manufacturing process for novel gene therapy to treat epilepsy

London, UK, and Lund, Sweden, 12 January 2018 – CGT Catapult and CombiGene today announced that they will be collaborating on a project to develop manufacturing processes for CombiGenes drug candidate CG01, a novel gene therapy for treatment of epilepsy. The collaboration aims to develop a complete and final manufacturing process which will allow CombiGene to progress to commercial GMP production and thereafter clinical trials. CombiGene is pioneering a new therapy with the potential of dramatically improving the quality of life for a group of epilepsy patients for whom there currently is no effective treatment available. CombiGene’s unique platform uses gene therapy vectors to deliver a combination of neuropeptide y (NPY) and NPY receptors into brain cells which has shown to inhibit epileptic seizures, in a series of preclinical studies.   “I am very proud and very pleased to be working with CGT Catapult,” says Jan Nilsson, CEO of CombiGene. “CGT Catapult is highly renowned for its cutting-edge competence and state-of-the-art infrastructure for advanced therapeutic medicinal products. We evaluated several potential collaborators, and we could not have chosen a better partner.” In addition to CGT Catapult’s capabilities in a range of critical areas such as manufacturing development and regulatory support, the organisation offers the possibility for its partners to commit to the individual steps in a development process one by one, something which is very important for CombiGene. “CombiGene is a small gene therapy company, and from a financial and funding point of view, the step-by-step approach is very attractive for us,” CombiGene’s chairman Arne Ferstad explains. In 2017, CombiGene finalized two important studies with highly promising results. Initial data from the preclinical proof-of-concept-study, show that CombiGene’s candidate drug, CG01, reduces the frequency of epileptic seizures in animals. Final data from the study will be presented during the first quarter of 2018. The second human expression study, initial data shows that the therapeutic genes encoded by CG01 are expressed in epileptic human tissue, thereby confirming that this method of administering genes encoded by the candidate drug is successful in human tissue. “We are delighted to be working with CombiGene to accelerate the commercialisation of an important gene therapy to treat an unmet medical need. It is testament to our international reputation and the capabilities that we offer that we continue to be the development partner of choice for innovative cell and gene companies.” says Keith Thompson, CEO, Cell and Gene Therapy Catapult About CombiGene AB By combining modern neuroscience with recent advances in gene delivery, CombiGene has developed a method shown to suppress epileptic seizures in preclinical studies. The current focus is on continuing to develop this method into an effective and safe therapy for epilepsy patients, but the method may also have development potential as a means of treating other neurological disorders. Founded on the basis of scientific discoveries made at Lund University and the University of Copenhagen, CombiGene has offices at Medicon Village in Lund, Sweden. The company is public and listed on the Swedish marketplace AktieTorget. www.combigene.com  For further information: CombiGene AB (publ) Jan Nilsson, CEOTel: +46 (0)704 66 31 63E-mail: jan.nilsson@combigene.com About the Cell and Gene Therapy Catapult The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 120 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise. Its aim is to make the UK the most compelling and logical choice for UK and international partners to develop and commercialise these advanced therapies. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk  or visit www.gov.uk/innovate-uk. For further information please contact: FTI Consulting for the CGT CatapultCon Franklin +44 (0) 203 319 5560 / con.franklin@fticonsulting.com  Michael Trace +44 (0) 203 319 5674 / michael.trace@fticonsulting.com This information is information that CombiGene AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted, by CEO Jan Nilsson, for publication on Januari 12 2018.

Alma Mediapartners strengthens its construction and housing software portfolio through company acquisition

Alma Media Corporation                                   Press release 12 January 2018 ALMA MEDIAPARTNERS STRENGTHENS ITS CONSTRUCTION AND HOUSING SOFTWARE PORTFOLIO THROUGH COMPANY ACQUISITION Alma Media’s subsidiary Alma Mediapartners Oy is strengthening its software business related to construction and housing by acquiring the entire share capital of Käyttösofta Oy from its founders. Käyttösofta’s revenue for 2017 was approximately EUR 1 million. The parties have agreed not to disclose the price of the transaction. The Talosofta software developed by Käyttösofta Oy is a web-based ERP system for small and medium-sized operators in the construction, renovation and technical building service industries. The Talosofta system allows users to manage entire accounts and projects comprehensively from sales to invoicing and it is integrated into several modern financial management systems. The company has approximately 100 clients at the moment. Talosofta will become part of Alma Mediapartners’ strong line of business that concentrates on housing. This includes Etuovi.com, Vuokraovi.com and Urakkamaailma.fi aimed at consumers, the Kivi real estate business system, and NettiKoti, which is used for the management of tenant changes and selections. ”In construction, digitization offers many possibilities for new business development as well as the creation of new service models. Our aim is to strengthen our software business, and the Talosofta software that encompasses the entire construction process fits our product portfolio perfectly,” says Riikka Wulff, Managing Director of Alma Mediapartners Oy. ”The Talosofta business operations are growing and developing. We are combining our strengths with those of Alma and our product will become a part of Alma’s selection, which will benefit the customer. We will continue active cooperation with our customers as before,” say CEO Jani Räihä and Petri Poukkula, co-founder of Käyttösofta Oy. For more information, please contact:Riikka Wulff, Managing Director of Alma Mediapartners Oy, tel. +358 10 665 3519Jani Räihä, CEO, Käyttösofta Oy, tel. +358 (0)10 544 1937

THE MARKETING GROUP PLC SUBSIDIARY MANAGEMENT TERMINATION AND WINDING UP OF BLACK MARKETING

London – 12 January 2018 - The Marketing Group plc (“TMG” or the “Group” or the “Company”) announces the immediate departure of Chris Reed, the principal of the Group’s subsidiary Black Marketing, from the Group and the winding up of the Black Marketing business. A specialist Linkedin marketing agency that primarily worked for SMEs, based in Singapore, Black Marketing was loss making and is not considered appropriate to be part of TMG.  TMG is currently considering its options regarding potential legal action against Chris Reed. The ordinary shares in the Company owned by Chris Reed are covered by an Orderly Market Agreement and the Company will be looking to ensure that its terms are abided by. For further information please contact: Adam Graham, CEO Email: investorrelations@tmg-plc.com Media Lydia Oakes Phone: +44 (0)7710 244573 Email: lydia@bluestripemedia.co.ukInvestor relationsTim Metcalfe Miles NolanPhone: +44 (0) 203 934 6630Email: investorrelations@tmg-plc.com The Marketing Group plc (“TMG”) in brief TMG is building a global full-service marketing network, powered by technology, that provides a fresh alternative for global brands that want to see more bang for their buck. With offices in America, Europe, Asia and Australasia, TMG’s collaborative network of agencies provide a holistic service to deliver highly effective results. The Marketing Group is listed on Nasdaq First North, Stockholm. www.tmg-plc.com. Mangold Fondkommission AB, +46 8-5030 15 50, is the company’s Certified Adviser and liquidity provider.

THE MARKETING GROUP PLC DISPOSAL OF SUBSIDIARY

London – 12 January 2018 - The Marketing Group plc (“TMG” or the “Group” or the “Company”) announces the disposal of its lifestyle marketing agency, Creative Insurgence. Aaghir Yadav, the co-founder of Creative Insurgence, has agreed to buy back the business through the return of 900,000 ordinary shares in the Company, which will be duly cancelled.  It has been agreed that the effective date of the disposal be 1 January 2017 so any losses incurred by Creative Insurgence for the year ended 31 December 2017 will not impact TMG. Commenting, Adam Graham, TMG CEO, said, “Creative Insurgence specialises in lifestyle marketing for bars, clubs and restaurants. It was acquired by the former management at TMG and we feel it will be better placed as a standalone entity. “We remain firmly supportive of Aaghir Yadav and wish both him and the team at Creative Insurgence a very successful future – indeed, we will continue to partner with them on some projects. For TMG shareholders, this is a further move which should help streamline our operations, bring tighter strategic fit to the group, and improve our financial performance.” For further information please contact: Adam Graham, CEO Email: investorrelations@tmg-plc.com Media Lydia Oakes Phone: +44 (0)7710 244573 Email: lydia@bluestripemedia.co.ukInvestor relationsTim Metcalfe Miles NolanPhone: +44 (0) 203 934 6630Email: investorrelations@tmg-plc.com The Marketing Group plc (“TMG”) in brief TMG is building a global full-service marketing network, powered by technology, that provides a fresh alternative for global brands that want to see more bang for their buck. With offices in America, Europe, Asia and Australasia, TMG’s collaborative network of agencies provide a holistic service to deliver highly effective results. The Marketing Group is listed on Nasdaq First North, Stockholm. www.tmg-plc.com. Mangold Fondkommission AB, +46 8-5030 15 50, is the company’s Certified Adviser and liquidity provider.

Nomination Committee’s proposal for the Board of Directors ahead of the Annual General Meeting of Starbreeze AB

STOCKHOLM (12 January 2018) - The Nomination Committee of Starbreeze AB has decided to propose to the Annual General Meeting 2018 that the Board be composed of seven ordinary members without alternates. The Nomination Committee proposes re-election of directors Ulrika Hagdahl, Michael Hjorth, Bo Andersson Klint, Harold Kim and Matias Myllyrinne, and election of Kristofer Arwin and Åsa Wirén. Michael Hjorth is proposed for re-election as Chairman. Director Eva Redhe has declined re-election. Kristofer Arwin, BSc in Business Administration and Economics, is Chairman and co-founder of TestFreaks, where he earlier served as CEO. He is the founder of Pricerunner, where he also served as CEO. Kristofer Arwin is a director and audit committee member of Kindred Group Plc (formerly Unibet Plc) and Addnode Group, as well as a director of Alertsec AB. Åsa Wirén, Master’s in Business Administration and Economics, is presently active as Senior Advisor at Bonnier and was formerly CFO of Skistar. She has been an authorised public accountant and partner at KPMG, with experience from listed companies and companies with international operations in sectors such as media/entertainment, e-commerce and consultancy/software. Åsa Wirén is a director and chair of the audit committee of Actic Group and director of N Å Future AB and Fjällförsäkringar AB. The Nomination Committee’s other proposals for the Annual General Meeting of Starbreeze AB, that will take place on Wednesday, May 9 this year, will be stated in the notice to the Meeting. The Nomination Committee of Starbreeze AB is composed of: Åsa Nisell, Swedbank Robur Fonder; Olof Jonasson, Första AP-fonden; and Michael Hjorth, Indian Nation AB and Chairman of Starbreeze AB.

Tomas Carlsson appointed new CEO of NCC

“I am delighted that Tomas Carlsson will be the next President of NCC. Tomas is highly familiar with NCC’s operations and he has been able to expand his expertise during his time at Sweco. He has gained experience in leading a consultancy firm and has also been able to observe how various construction companies operate in the market. Sweco’s stock-market performance has been strong, with the company’s share price tripling. Tomas’s project experience is a perfect fit for NCC,” says Tomas Billing, Chairman of NCC. Tomas Carlsson has been the President of Sweco since the end of 2012. During his time as President, the company increased its sales from approximately SEK 8 billion to approximately SEK 17 billion with a stable operating margin. Tomas previously served as Head of NCC’s construction operations in Sweden which at the time generated sales of approximately SEK 25 billion and accounted for about half of NCC’s sales. Tomas is 52 years old. He holds a Master of Science in Engineering from Chalmers University of Technology and an Executive MBA from London Business School and Columbia Business School. “It feels like coming home. I am very much looking forward to leading NCC and see great potential for developing the operations,” says Tomas Carlsson. Tomas Carlsson will take up his new position at NCC by July 2018 at the latest. Håkan Broman will serve as acting President in the interim. “Naturally, I hope that Tomas will start working before the summer. Until then, we have an excellent acting President, Håkan Broman. Håkan has already taken measures to reduce overheads and has also recruited a new strong leader for the Infrastructure business area, Kenneth Nilsson from Skanska, who will take office in April,” says Tomas Billing.

Trading in warrants TO1 2017/2020 commences on January 16, 2018

Terms of the warrant of series TO1 2017/2020 in brief: -        Warrants will be listed for trading on AktieTorget on January 16, 2018 -        Holding of one (1) warrant entitle the holder to subscribe for one (1) new share at an exercise price of 3.20 SEK -        Subscription of new shares by exercising the warrants for an aggregate exercise amount of 500 000 SEK or more can take place at any time during the maturity period (i.e. any day during the 3-year period ending on December 13, 2020) -        Subscription of new shares by exercising the warrants for an aggregate exercise amount of 500 000 SEK or less can only take place at six occasions: · o   16 May 2018 up until 30 May 2018 · o   31 October 2018 up until 14 November 2018 · o   17 April 2019 up until 1 May 2019 · o   2 October 2019 up until 16 October 2019 · o   18 March 2020 up until 1 April 2020 · o   2 September 2020 up until 16 September 2020 -        Warrants of series TO1 2017/2020 have ISIN code SE0010714576 The full terms and conditions of the Warrants are published on Camanio Care's website: http://www.camanio.com/en/invest/ For further information, please contact:Catharina Borgenstierna, CEOTelephone: 0733-93 00 07E-mail: catharina.borgenstierna@camanio.com  About Camanio CareCamanio Care is a company operating in the caretech marketplace with robotics, assistive devices and gamification that focus on supporting basic human needs. We provide products and services that improve quality and efficiency in the areas of Active Life, Mealtime Situation and Digital Care with products such as BikeAround™, Giraff and Bestic®. Camanio Care has its headquarters in Stockholm, Sweden, subsidiaries in the USA and distributors in ten European countries and also Australia and China. We make the future work!  Subscribe to our newsletter and/or read more about us, Camanio Care at:  www.camanio.com.

YIT raises its estimate regarding the adjusted operating profit for 2017 and books a cost related to revaluation of balance sheet items

YIT provides preliminary financial information regarding the adjusted operating profit and revenue for 2017 (segment reporting, POC). In 2017, YIT’s preliminary adjusted operating profit was approximately EUR 122 million (2016: EUR 79.9 million) and preliminary revenue approximately EUR 1,908 million (2016: EUR 1,783.6 million). The revenue increased approximately by 7 per cent from the previous year. The figures are based on unaudited preliminary financial results for the reporting period. The preliminary adjusted operating profit exceeds the given guidance and the preliminary revenue is in accordance with the guidance. The more positive development of the Group adjusted operating profit is due to stronger than expected last quarter in all segments and especially the strong result in December. The result estimate is raised by good residential sales in Finland and in the CEE countries as well as the pick-up of residential sales in Russia compared to the beginning of the year. The Business Premises and Infrastructure segment succeeded in closing all the pending property transactions during December. Previous guidance for 2017 (segment reporting, POC, published on July 13, 2017) The Group revenue is estimated to grow by 5–12%. The adjusted operating profit is estimated to be in the range of EUR 105–115 million. The adjusted operating profit does not include material reorganisation costs, impairment charges or other items affecting comparability. Adjusting items in the last quarter YIT revaluates balance sheet values of several plots or balance sheet items in Finland and Lithuania reported under Business Premises and Infrastructure and Housing Finland and CEE segments. Only minor revaluations were made in Housing Russia segment. The cost to be booked now will be EUR 14 million at the most. In addition, in the fourth quarter the adjusting items related to the preparation of the planned merger between YIT and Lemminkäinen were approximately EUR 2 million. In 2017, the adjusting items related to the planned merger were approximately EUR 6 million in total.  The adjusting items reduce the operating profit for the reporting period, but they do not have an impact on the adjusted operating profit given to the guidance. The revaluation of balance sheet items does not have an impact on the cash flow in 2017. YIT’s Financial Statements Bulletin for 2017 will be published on Thursday, February 1, 2018. YIT is currently on silent period and will comment its results and outlook next time after the publishing of the Financial Statements Bulletin. For further information, please contact: Hanna Jaakkola, Vice President, Investor Relations, YIT Corporation, tel. +358 40 5666 070, hanna.jaakkola@yit.fi  Esa Neuvonen, Chief Financial Officer, YIT Corporation, tel. +358 40 500 1003, esa.neuvonen@yit.fi   YIT CORPORATION Hanna Jaakkola Vice President, Investor Relations Distribution: Nasdaq Helsinki, major media, www.yitgroup.com YIT creates better living environment by developing and constructing housing, business premises, infrastructure and entire areas. Our vision is to bring more life in sustainable cities. We want to focus on caring for customer, visionary urban development, passionate execution and inspiring leadership. Our growth engine is urban development involving partners. Our operating area covers Finland, Russia, the Baltic countries, the Czech Republic, Slovakia and Poland. In 2016, our revenue amounted to nearly EUR 1.8 billion, and we employ about 5,300 employees. Our share is listed on Nasdaq Helsinki. www.yitgroup.com IMPORTANT NOTICE The distribution of this release may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restrictions. The information contained herein is not for publication or distribution, directly or indirectly, in or into Canada, Australia, Hong Kong, South Africa or Japan. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This release is not directed to, and is not intended for distribution to or use by, any person or entity that is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction. No part of this release, nor the fact of its distribution, should form the basis of, or be relied on in connection with, any contract or commitment or investment decision whatsoever. The information contained in this release has not been independently verified. No representation, warranty or undertaking, expressed or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or the opinions contained herein. Neither YIT nor Lemminkäinen, nor any of their respective affiliates, advisors or representatives or any other person, shall have any liability whatsoever (in negligence or otherwise) for any loss however arising from any use of this release or its contents or otherwise arising in connection with this release. Each person must rely on their own examination and analysis of YIT, Lemminkäinen, their respective subsidiaries, their respective securities and the merger, including the merits and risks involved. Notice to Lemminkäinen Shareholders in the United States The YIT shares to be issued in connection with the merger have not been registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and are being issued in reliance on the exemption from registration set forth in Rule 802 under the Securities Act.  YIT and Lemminkäinen are Finnish companies and the issuance of YIT shares will be subject to procedural and disclosure requirements in Finland that may be different from those of the United States. Any financial statements or other financial information included in this release may have been prepared in accordance with non-U.S. accounting standards that may not be comparable to the financial statements of U.S. companies or companies whose financial statements are prepared in accordance with generally accepted accounting principles in the United States. It may be difficult for U.S. shareholders of Lemminkäinen to enforce their rights and any claims they may have arising under U.S. federal securities laws in connection with the merger, since YIT and Lemminkäinen are located in non-U.S. jurisdictions, and some or all of YIT's and Lemminkäinen's officers and directors may be residents of countries other than the United States. As a result, U.S. shareholders of Lemminkäinen may not be able to sue YIT or Lemminkäinen or their respective officers and directors in a court in Finland for violations of U.S. federal securities laws. Further, it may be difficult to compel YIT or Lemminkäinen to subject themselves to the jurisdiction or judgment of a U.S. court. Lemminkäinen’s shareholders should be aware that YIT may purchase Lemminkäinen’s shares otherwise than under the merger, such as in open market or privately negotiated purchases, at any time during the pendency of the proposed merger. Notice to Shareholders in the United Kingdom This release, the merger prospectus and the English language offering circular are for distribution only to persons who (i) have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the "Financial Promotion Order"), (ii) are persons falling within Article 43 of the Financial Promotion Order (for example as shareholders in Lemminkäinen entitled to receive the merger consideration shares pursuant to the Finnish Companies Act (21.7.2006/624, as amended)), (iii) are persons falling within Article 49(2)(a) to (d) ("high net worth companies, unincorporated associations etc.") of the Financial Promotion Order, (iv) are outside the United Kingdom, or (v) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of the merger consideration shares may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "relevant persons"). The release, the merger prospectus and the English language offering circular are directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which these documents relate, are available only to relevant persons and will be engaged in only with relevant persons. Notice to Shareholders in the European Economic Area The English language offering circular has been prepared on the basis that any offer of the merger consideration shares in any Member State of the European Economic Area ("EEA") other than offers (the "Permitted Public Offers") which are made prior to the Effective Date (as defined in the English language offering circular), and which are contemplated in the English language offering circular in Finland once the Finnish language merger prospectus has been approved by the competent authority in Finland and published in accordance with the Prospectus Directive, and in respect of which YIT has consented in writing to the use of the English language offering circular, will be made pursuant to an exemption under the Prospectus Directive from the requirement to publish a prospectus for offers of the merger consideration shares. Accordingly any person making or intending to make an offer in that Member State of the merger consideration shares which are the subject of the offer contemplated in the English language offering circular, other than the Permitted Public Offers, may only do so in circumstances in which no obligation arises for YIT to publish a prospectus pursuant to Article 3 of the Prospectus Directive or supplement a prospectus pursuant to Article 16 of the Prospectus Directive, in each case, in relation to such offer. YIT has not authorised, nor does it authorise, the making of any offer (other than Permitted Public Offers) of the merger consideration shares in circumstances in which an obligation arises for YIT to publish or supplement a prospectus for such offer. In relation to each Member State of the EEA, with effect from and including the date on which the Prospectus Directive was implemented in that Member State (the "Relevant Implementation Date") no offer has been made and will not be made (other than a Permitted Public Offer) of the merger consideration shares which are the subject of the offering contemplated by the English language offering circular to the public in that Member State, except that, with effect from and including the Relevant Implementation Date, an offer of such merger consideration shares is made to the public in that Member State: a)       to any legal entity which is a qualified investor as defined in the Prospectus Directive; b)      to fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted under the Prospectus Directive, subject to obtaining the prior consent of YIT for any such offer; or c)       in any other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no offer of the merger consideration shares is made which would require YIT to publish a prospectus pursuant to Article 3 of the Prospectus Directive or supplement a prospectus pursuant to Article 16 of the Prospectus Directive. The expression an offer of the merger consideration shares to the public in relation to any merger consideration shares in any Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the merger consideration shares to be offered so as to enable an investor to decide to purchase or subscribe to the merger consideration shares, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State. The expression "Prospectus Directive" means Directive 2003/71/EC (as amended), and includes any relevant implementing measure in the EEA Member State concerned.

Aftonbladet and NBC News in international cooperation – strengthens journalism with news and documentaries

Aftonbladet and NBC News, a global leader in news across all broadcast and digital platforms, are teaming up in 2018. The collaboration will provide Aftonbladet with access to moving images at major news events worldwide, access to reports from the field, and online-adapted in-depth news material. NBC News will provide Aftonbladet with up to eight simultaneous live streams and a wide range of news clips from the network’s award-winning journalists and their established roster of affiliates.  “With the current political news cycle in the United States, the great interest in international news events, and users’ increased demands for live presence, it is exceptionally gratifying to partner with a global news organization like NBC News,” says Martin Ekelund, news director at Aftonbladet TV. In February 2017, NBC News Group joined forces with Euronews to combine the power of the NBC News brand with the formidable news asset in Europe in order to create an international offering that will strengthen both news organizations and change the landscape of international news. This growth continues with the addition of Aftonbladet.  “This is a very exciting time for NBC News as we expand our leadership position as the most consumed US news brand globally. International consumers will increasingly benefit from our world class journalism and continued investment.  Partnering with Aftonbladet will bring our exceptional reporting to Sweden,” says Adrienne Mong, Vice President of International Newsgathering for NBC News. Viewers will also have access to NBC Left Field, a new unit that produces cinematic, digital-first, and often international short- and mid-form documentaries. In-depth reporting on technology and innovation, as well as lifestyle and wellness will also be available to Aftonbladet users.

Instalco grows in southern Sweden

VVT was founded in 1998 by Tony Svensson and Lars Jönsson as a service company in ventilation and heating. In addition to installations of heating and ventilation, the company is today also active in the home automation area with security systems and alarms. VVT also carries out all types of electrical installations. The company employs 13 people and preliminary net sales for the 2017 financial year amounted to approximately SEK 20 million. “With the acquisition of VVT, we continue to grow and strengthen our position in the Skåne region. VVT is a small and well-managed company with operations within several of our areas of technical expertise, which fits well with Instalco”, Patrik Persson, Head of Business Area South at Instalco. VVT is owned by Tony Svensson and Mikael Nordqvist, who both will continue to work for the company. “We have a broad offering while also being specialists. Now we look forward to VVT’s next step by becoming part of Instalco and all business opportunities that will open up”, says Tony Svensson, CEO of VVT. Instalco acquires 100% of VVT, with completion today 12 January 2018. For more informationPer Sjöstrand, CEO Instalcophone +46 70 724 51 49, e-mail per.sjostrand@instalco.se  Adrian Westman, Head of Investor Relationsphone +46 73 509 04 00, e-mail adrian.westman@instalco.se  Instalco is one of the leading installation companies in the Nordic region, active in the areas of heating, plumbing, electricity, cooling and industrial solutions. We work closely with customers, offering all the advantages of a local company, along with efficient collaboration and leadership. The operations are conducted through approximately 40 leading and highly specialised local companies, with the support of a small central organisation. Instalco is listed at Nasdaq Stockholm under the ticker INSTAL. For further information, visit www.instalco.se.

Mölnlycke partners with Tissue Analytics to simplify and standardize chronic wound care

The two parties will jointly develop and commercialize innovative digital solutions for wound care practitioners including comprehensive clinical decision support tools that will significantly simplify and standardize wound assessment and treatment. Today, practitioners are constrained by the quality of data available for wound assessment. Conditions, such as chronic wounds, burns and pressure ulcers are evaluated using only visual approximations. Tissue Analytics (TA) develops software solutions that use artificial intelligence to automatically and objectively extract high quality data from input and images. Through partnerships with Epic, Cerner, Allscripts, and other EMRs (Electronic Medical Record), the extracted data can automatically be integrated into the institution’s EMR system to allow efficiency and improved workflows. Mölnlycke and Tissue Analytics will jointly develop TA’s existing software, adding Mölnlycke’s expertise in wound management and undertake extensive testing with clinical partners to ensure the best clinical and patient outcomes. In addition, Mölnlycke has acquired a minority equity interest in Tissue Analytics that further solidifies the underlying strategic partnership.   “Mölnlycke is a world-leading producer of premium wound care products, and we bring to market new innovative solutions. However, we want to do more. By providing health care professionals with a combination of high quality products and advanced tools to allow consistent care delivery, we will not only help them in their daily job, but also improve patient outcomes. The partnership with Tissue Analytics represents a very exciting opportunity to make this happen”, says Richard Twomey, CEO, Mölnlycke. Kevin Keenahan, CEO of Tissue Analytics, comments: “Tissue Analytics is incredibly excited to work with Mölnlycke on this important initiative. We share the same passion to help patients, and with our expertise in digital medicine and their extensive knowledge of wound healing, we can bring powerful, new data analytics capabilities to the market.”

Loudspring Increases Focus on ResQ Club

We are pleased to have just announced an additional investment into ResQ Club, which will be the start of a new funding round that we are leading. ResQ continues to excite us every day with their mission and progress. As they continue to hit key milestones we will continue to support their growth. This investment is in line with our updated strategy, and is part of an increasing focus on our portfolio and consolidation of our holdings. Here is some background on ResQ. ResQ Club is a marketplace for surplus food. Restaurants, cafeterias and grocery stores can reduce their food waste – and thus, their carbon ‘foodprint’ – by selling their surplus food to consumers at a 40-70% discount. For consumers, ResQ is an easy and sustainable way to discover and purchase affordable meals nearby their location. Consumers can discover and purchase meals either via iOS, Android and desktop application and collect those from a restaurant. Around 88 million tonnes of food is wasted annually in the EU alone. The associated costs of this waste is estimated at 143 Billion Euros. Furthermore, the agricultural process that is taking place just to produce surplus food comes at a huge burden to the environment. To us, this is a dramatic market failure. Enter Digital Food. ResQ Club’s business is at the heart of digital food, a rapidly emerging global megatrend that has already created multibillion dollar companies from start up’s and that continues to change the urban lifestyle around the world. ResQ Club lets you find meals that otherwise would go to waste at heavily discounted prices, giving users the possibility to purchase inexpensive high-quality restaurant food, and at the same time get to know new restaurants. The company has shown solid and impressive growth month-on-month since its launch in January 2016. The potential market for rescuing perfectly good meals is greater than 20 BNEUR in Europe alone and similar in the US. With the competition focused on delivery rather than efficiency, we see a great future for ResQ. ResQ has over 200,000 registered users in Finland, Sweden, The Netherlands and Germany. ResQ was launched in February 2016, since then people have ‘resqued’ close to 500,000 meals and over 1900 restaurants have made offers via ResQ. Through a platform such as ResQ we can cut food waste in restaurants and food outlets. This saving comes at the end of the process; this means the food has been grown, transported and prepared to eat. A lot of work gone to waste. The ability to “ResQ” will have a drastic impact on the amount of natural resources needed to keep urban populations fed. Get to know ResQ Club  Homepage: https://resq-club.com/ Facebook: https://www.facebook.com/resqclubglobal/ Instagram: https://www.instagram.com/resqclub/ Twitter: https://twitter.com/resqclub  Press photos about ResQ Club: https://drive.google.com/drive/folders/0B6bAXWFJZVq_WG95Tk04alpGLTA 

Publication of supplement to prospectus

Financial advisor Sedermera Fondkommission is the financial advisor to Oncology Venture in connection with the rights issue.  For questions concerning the rights issue, please contact: Sedermera Fondkommission Telephone: +46 (0) 40-615 14 10 E-mail: info@sedermera.se  For further information, please contact Ulla Hald Buhl, COO and Or Peter Buhl Jensen, CEOMobile: +45 21Chief IR & 60 89 22E-mail:CommunicationsMobile: pbj@oncologyventure.com+45 2170 1049E-mail:uhb@oncologyventure.com About Oncology Venture Sweden AB Oncology Venture Sweden AB is engaged in the research and development of anti-cancer drugs via its wholly owned Danish subsidiary Oncology Venture ApS. Oncology Venture has a license to use Drug Response Prediction – DRP® – in order to significantly increase the probability of success in clinical trials. DRP® has proven its ability to provide a statistically significant prediction of clinical outcomes from drug treatment in cancer patients in 29 of the 37 clinical studies that were examined. The Company uses a model that alters the odds in comparison with traditional pharmaceutical development. Instead of treating all patients with a particular type of cancer, patients’ tumors genes are screened first and only those who are most likely to respond to the treatment will be treated. Via a more well-defined patient group, the risk and costs are reduced while the development process becomes more efficient. The current product portfolio: LiPlaCis® for Breast Cancer in collaboration with Cadila Pharmaceuticals, Irofulven developed from a fungus for prostate cancer and APO010 – an immuno-oncology product for Multiple Myeloma. Oncology Venture has spun out two companies in Special Purpose Vehicles: 2X Oncology Inc. a US based company focusing on Precision medicine for women’s cancers with a pipeline of three promising phase 2 product candidates. OV-SPV 2 is a Danish company that shall test and potentially develop an oral phase 2 Tyrosine Kinase inhibitor. Oncology Venture currently holds 92 percent of the shares in 2X Oncology Inc. and 40 percent of the shares in OV-SPV 2.

FDA approves Lynparza for metastatic breast cancer

12 January 2018 16:10 GMT LYNPARZA APPROVED BY US FDA IN GERMLINE BRCA-MUTATED  METASTATIC BREAST CANCER Lynparza is the first and only PARP inhibitor approved for use beyond ovarian cancer Lynparza reduced the risk of disease progression or death by 42% compared to standard of care chemotherapy AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) today announced that the US Food and Drug Administration (FDA) has approved Lynparza (olaparib), for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting. Patients with hormone receptor positive (HR+) breast cancer should have been treated with a prior endocrine therapy or be considered inappropriate for endocrine therapy. Patients are selected for therapy based on an FDA-approved companion diagnostic from Myriad Genetics. Dave Fredrickson, Executive Vice President, Head of the Oncology Business Unit, AstraZeneca, said: "This new approval for Lynparza makes it the first and only PARP inhibitor approved in metastatic breast cancer, and the only PARP inhibitor approved beyond ovarian cancer. This is significant for breast cancer patients, as the identification of BRCA status, in addition to hormone receptor and HER2 status, becomes a potentially critical step in the management of their disease." Roy Baynes, Senior Vice President and Head of Global Clinical Development, Chief Medical Officer, Merck Research Laboratories said: "This additional approval for Lynparza represents an important advance for women with HER2-negative metastatic breast cancer with a germline BRCA mutation, which is a difficult-to-treat cancer. Moreover, this approval adds further impetus to our important collaboration with AstraZeneca in developing cancer therapies."  The approval was based on data from the randomised, open-label, Phase III OlympiAD trial  which investigated Lynparza versus physician's choice of chemotherapy (capecitabine, eribulin, or vinorelbine). In the trial, Lynparza significantly prolonged progression-free survival (PFS) compared with chemotherapy, and reduced the risk of disease progression or death by 42% (HR 0.58; 95% CI 0.43-0.80; P=0.0009 median 7.0 vs 4.2 months). Patients with measurable disease taking Lynparza (n=167) experienced an objective response rate of 52% (95% CI 44-60), double the response rate for those in the chemotherapy arm (n=66) which was 23% (95% CI 13-35). Additionally, patients experienced a confirmed complete response rate of 7.8% for Lynparza compared to 1.5% for the chemotherapy arm. The data from the OlympiAD trial can be found in the June 2017 issue of the New England Journal of Medicine . Susan M. Domchek, Executive Director of the Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, and a national leader on the OlympiAD trials, said: "Patients diagnosed with BRCA-related metastatic breast cancer are often younger than other breast cancer patients, and their disease is often much more aggressive and difficult to treat. While there is currently no cure for metastatic breast cancer, today's approval offers a new, targeted option that may help to delay disease progression for these patients."  The most common adverse reactions (≥20%) in the OlympiAD trial of patients who received Lynparza were nausea (58%), anaemia (40%), fatigue (including asthenia) (37%), vomiting (30%), neutropenia (27%), respiratory tract infection (27%), leukopenia (25%), diarrhoea (21%), and headache (20%). The percentage of patients who discontinued treatment in the Lynparza arm was 5% compared to the chemotherapy arm which was 8%. This is the third indication approved for Lynparza in the US, where it has been used to treat nearly 4,000 advanced ovarian cancer patients. Lynparza has the broadest clinical development programme of any PARP inhibitor, and AstraZeneca and MSD are working together to deliver Lynparza as quickly as possible to more patients across multiple settings, including breast, ovarian, prostate and pancreatic cancers. Sustainable and Ongoing Externalisation Revenue Under the oncology collaboration with Merck, announced in July 2017, AstraZeneca is potentially eligible for more than $6 billion of future Sustainable and Ongoing Externalisation Revenue in the form of sales-related and approval-related payments in addition to option payments until 2019. Following this new approval for Lynparza, AstraZeneca will receive $70 million in Sustainable and Ongoing Externalisation Revenue. About OlympiAD OlympiAD is a randomised, open-label, multicentre Phase III trial assessing the efficacy and safety of Lynparza tablets (300 mg twice daily) compared to physician's choice of chemotherapy in 302 patients with HER2-negative metastatic breast cancer with germline BRCA1 or BRCA2 mutations, which are confirmed or suspected to be deleterious. The international trial was conducted in 19 countries across Europe, Asia, North America and South America. Patients in the OlympiAD trial had HER2-negative gBRCA1- or gBRCA2-mutated breast cancer, which was HR+ or triple negative, and received Lynparza for metastatic disease. Approximately half of the patients in the Lynparza and chemotherapy arm of the trial were HR+ (n=152), and approximately half were triple negative (n=150). Among the 205 patients treated with Lynparza, the median age was 44 years (range: 22 to 76). Before enrolment, patients had prior treatment with an anthracycline (unless contraindicated) and a taxane chemotherapy either in the neoadjuvant, adjuvant or metastatic setting and no more than two prior lines of chemotherapy for metastatic disease. Hormone receptor-positive patients had received at least one endocrine medicine or were not eligible for endocrine medicines. Prior treatments with endocrine medicines were not counted as prior lines of chemotherapy. The primary endpoint of the trial was PFS as measured by a Blinded Independent Central Review. Secondary endpoints included overall survival, time to second progression or death, objective response rate, and effect on health-related quality of life. About Metastatic Breast Cancer (MBC) Three main receptors drive tumour growth in breast cancer: progesterone receptors (PR), estrogen receptors (ER) and HER2 receptors. A patient's breast cancer will test either negative or positive for these three receptors. If a tumour tests positive for PR and/or ER, it is considered HR+. If a tumour tests negative for all three receptors, it is considered triple negative. MBC is the most advanced stage of breast cancer (Stage IV), and occurs when cancer cells have spread beyond the initial tumour site to other parts of the body outside of the breast. Despite the increase in treatment options during the past three decades, there is currently no cure for patients diagnosed with MBC and only 26.9% of patients survive five years after diagnosis. Thus, the primary aim of treatment is to slow progression of the disease for as long as possible, improving, or at least maintaining, a patient's quality of life. It is estimated that in 2018, there will be approximately 155,000 women in the US living with MBC, and this number is projected to increase to approximately 160,000 by the year 2020. About Germline BRCA Mutations BRCA1 and BRCA2 are human genes that produce proteins responsible for repairing damaged DNA and play an important role maintaining the genetic stability of cells. When either of these genes is mutated, or altered, such that its protein product either is not made or does not function correctly, DNA damage may not be repaired properly and cells become unstable. As a result, cells are more likely to develop additional genetic alterations that can lead to cancer. About Lynparza (olaparib) Lynparza is the first FDA-approved oral poly ADP-ribose polymerase (PARP) inhibitor and the first targeted treatment to potentially exploit DNA damage response (DDR) pathway deficiencies, such as BRCA mutations, to preferentially kill cancer cells. Specifically, in vitro studies have shown that Lynparza-induced cytotoxicity may involve inhibition of PARP enzymatic activity and increased formation of PARP-DNA complexes, resulting in DNA damage and cancer cell death. Lynparza is being investigated in a range of DDR-deficient tumour types and is the foundation of AstraZeneca's industry-leading portfolio of compounds targeting DDR mechanisms in cancer cells. About the AstraZeneca and MSD Strategic Oncology Collaboration In July 2017, AstraZeneca and Merck & Co., Inc., Kenilworth, NJ, US, known as MSD outside the United States and Canada, announced a global strategic oncology collaboration to co-develop and co-commercialise Lynparza, the world's first PARP inhibitor, and potential new medicine selumetinib, a MEK inhibitor, for multiple cancer types. The collaboration is based on increasing evidence that PARP and MEK inhibitors can be combined with PD-L1/PD-1 inhibitors for a range of tumour types. Working together, the companies will develop Lynparza and selumetinib in combination with other potential new medicines and as a monotherapy. Independently, the companies will develop Lynparza and selumetinib in combination with their respective PD-L1 and PD-1 medicines. About AstraZeneca in Oncology AstraZeneca has a deep-rooted heritage in Oncology and offers a quickly growing portfolio of new medicines that has the potential to transform patients' lives and the Company's future. With at least six new medicines to be launched between 2014 and 2020 and a broad pipeline of small molecules and biologics in development, we are committed to advance New Oncology as one of AstraZeneca's five Growth Platforms focused on lung, ovarian, breast and blood cancers. In addition to our core capabilities, we actively pursue innovative partnerships and investments that accelerate the delivery of our strategy as illustrated by our investment in Acerta Pharma in haematology. By harnessing the power of four scientific platforms - Immuno-Oncology, Tumour Drivers and Resistance, DNA Damage Response and Antibody Drug Conjugates - and by championing the development of personalized combinations, AstraZeneca has the vision to redefine cancer treatment and one day eliminate cancer as a cause of death. About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.  For more information, please visit www.astrazeneca.com and follow us on Twitter @AstraZeneca. Media RelationsEsra Erkal-Paler UK/Global +44 203 749 5638Karen Birmingham UK/Global +44 203 749 5634Rob Skelding UK/Global +44 203 749 5821Matt Kent UK/Global +44 203 749 5906Gonzalo Viña UK/Global +44 203 749 5916Jacob Lund Sweden +46 8 553 260 20Michele Meixell US +1 302 885 2677 Investor RelationsThomas Kudsk Larsen +44 203 749 5712Craig Marks Finance, Fixed Income, M&A +44 7881 615 764Henry Wheeler Oncology +44 203 749 5797Mitchell Chan Oncology; Other +1 240 477 3771Christer Gruvris Brilinta; Diabetes +44 203 749 5711Nick Stone Respiratory; Renal +44 203 749 5716US toll free +1 866 381 7277 Adrian KempCompany SecretaryAstraZeneca PLC

Clas Ohlson increases sales in December 2017

Compared with the same month previous year, the net store portfolio was expanded by12 stores. At the end of the period, the total number of stores was 225. Sales in December is distributed as follows: +-------------------------+--------+--------+-----------------+------------------+|Countries, MSEK |December|December|Percentage change|Percentage change,|| |2017/18 |2016/17 | |local currency |+-------------------------+--------+--------+-----------------+------------------+|Sweden |536 |513 |4 |4 |+-------------------------+--------+--------+-----------------+------------------+|Norway |518 |506 |2 |9 |+-------------------------+--------+--------+-----------------+------------------+|Finland |166 |148 |12 |9 |+-------------------------+--------+--------+-----------------+------------------+|Outside Nordic countries*|42 |43 |-3 |-2 |+-------------------------+--------+--------+-----------------+------------------+| |1,261 |1,210 |4 |7 |+-------------------------+--------+--------+-----------------+------------------+ *Effected by store optimization in the UK.  Total sales during the first eight months of the fiscal year (May to December 2017) increases by 2 per cent to 5,932 MSEK (5,838). In local currencies, sales increases by 3 per cent versus previous year. The third quarter interim report 2017/18 will be published at 07:00 CET on Wednesday14 March 2018. The report will be presented on the same day at 08:30 CET. For more information, please contact:Sara Kraft Westrell, Director of Information and Investor Relations, phone +46 247 649 13 This is information that Clas Ohlson AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 7:00 am CET on 15 January 2018.

Resurs recruits Chief Commercial Officer

Anna Nauclèr, who is currently Country Sales Manager Sweden at Unilever Food Solutions, has been recruited as Chief Commercial Officer, and Deputy CEO, of Resurs Bank. She will take office in the spring of 2018 and become a member of Group Management. “Anna’s experience and strong sales drive with documented results of creating profitable growth will be of great benefit to Resurs. I look forward to welcoming Anna to our Group Management and continuing to develop Resurs together,” says Kenneth Nilsson, President and CEO of Resurs Holding. More information is available from: Kenneth Nilsson, President & CEO Resurs Holding, kenneth.nilsson@resurs.se +46 736 61 20 60 About Resurs:Resurs Holding (Resurs), which operates through the subsidiaries Resurs Bank and Solid Försäkring, is the leader in retail finance in the Nordic region, offering payment solutions, consumer loans and niche insurance products. Since its start in 1977, Resurs Bank has established itself as a leading partner for sales-driven payment and loyalty solutions in retail and e-commerce, and Resurs has thus built a customer base of approximately 5.5 million private customers in the Nordics. Resurs Bank has had a banking licence since 2001 and is under the supervision of the Swedish Financial Supervisory Authority. The Resurs Group operates in Sweden, Denmark, Norway and Finland. At the end of the third quarter of 2017, the Group had 752 employees and a loan portfolio of SEK 23.2 billion. Resurs is listed on Nasdaq Stockholm, Large Cap.

Approved Prospectus and start of subscription period

Reference is made to Nordic Mining ASA's ("Nordic Mining" or the "Company") stock exchange notice dated 14 December 2017 regarding the Private Placement and the Subsequent Offering. The Company will today publish the Prospectus in connection with the Private Placement and the Subsequent Offering, the terms and conditions for which were announced on 14 December 2017/8 January 2018. The Financial Supervisory Authority of Norway (Finanstilsynet) has reviewed and approved the Company's Prospectus regarding: (1) Listing on Oslo Axess of 15,625,000 new shares issued in connection with the Private Placement completed on 14 December 2017 at a subscription price per share of NOK 3.20; and (2) Subsequent Offering and listing on Oslo Axess of up to 3,000,000 new shares ("Offer Shares") at a price of NOK 3.20 per Offer Share with Subscription Rights for shareholders in Nordic Mining as of close of the Oslo Stock Exchange on 14 December 2017, as registered in the Norwegian Central Securities Depository (VPS) on 18 December 2017 (the "Record Date"), who were not offered shares in the Private Placement and are not resident in a jurisdiction where such offering would be unlawful, or would (in jurisdictions other than Norway) require any prospectus filing, registration or similar action), the "Eligible Shareholders". In the Subsequent Offering, each Eligible Shareholder has been granted non-transferrable allocation rights ("Subscription Rights") corresponding with their pro rata ownership as per Record Date. Eligible Shareholders has received 0.033171 Subscription Rights for every one share held based on their shareholding. The number of Subscription Rights issued to each Existing Shareholder has been rounded down to the nearest whole Subscription Right. Each Subscription Right gives the right to subscribe for and be allocated one Offer Share in the Subsequent Offering. Over subscription in the Subsequent Offering is allowed. The following allocation criteria will be used for allotment of Offer Shares in the Subsequent Offering: (1) Offer Shares shall be allocated on the basis of exercised Subscription Rights; (2) In the event that not all Offer Shares are allotted by exercising Subscription Rights, the Eligible Shareholders that have subscribed for more Offer Shares than they are entitled to shall be allocated Offer Shares in accordance with the principles set forth in the Public Limited Companies Act Section 10-4. The Subscription Period for the Subsequent Offering is from 15 January 2018 to 26 January 2018 at 16:30 CET. Please note that Subscription Rights that are not used to subscribe for Offer Shares before the expiry of the Subscription Period will be of no value and lapse will without compensation to the holder. Allocation of the Offer Shares is expected to take place on or about 29 January 2018. Notifications of allocated Offer Shares in the Subsequent Offering and the corresponding amount to be paid by each subscriber will be set out in a letter from the VPS, which will be distributed on or about 30 January 2018. It is expected that payment for Offer Shares will be made on 2 February 2018. Trading in Offer Shares on Oslo Axess is expected to commence on or about 8 February 2018. The Offer Shares will be delivered through the facilities of the VPS. The Managers of the Subsequent Offering are Carnegie AS and Swedbank, and Kvale Advokatfirma is legal advisor for the Subsequent Offering. The Prospectus together with the Subscription Form will be available at www.nordicmining.com, www.carnegie.no and www.swedbank.no. The Prospectus will also be available free of charge at the business offices of Nordic Mining ASA and the Managers. For questions please contact CFO Lars K. Grøndahl, telephone +47 901 60 941.Oslo, 15 January 2018Nordic Mining ASANordic Mining ASA (www.nordicmining.com) Nordic Mining ASA ("Nordic Mining" or "the Company") is a resource company with focus on high-end industrial minerals and metals in Norway and internationally. The Company's project portfolio is of high international standard and holds a significant economic potential. The Company's assets are in the Nordic region.Nordic Mining is undertaking a large-scale project development at Engebø on the west coast of Norway where the Company has rights and permits to a substantial eclogite deposit with rutile and garnet. Permits for the project have been granted by the Norwegian government, and a prefeasibility study was completed in October 2017. Nordic Mining's associated company Keliber in Finland is in the process of completing its definitive feasibility study and preparing for production of lithium carbonate. Nordic Mining has rights for exploration and production of high-purity quartz in Kvinnherad in Norway. Further, the Company holds exploration rights at Reinfjord in northern Norway where a prospective area of sulphide mineralisation has been discovered. Nordic Mining is also exploring opportunities related to seabed mineral resources. Nordic Mining is listed on Oslo Axess with ticker symbol "NOM".

Fazer’s restaurants provide brain-friendly food

“At the heart of our business is care for the customer, and our mission is ‘Food with a purpose’. With the Fazer Brainhow campaign, we offer brain-friendly lunches and snacks in January and February to help you take better care of yourself. Much attention is paid to the well-being of the rest of the body, but in fact our brains need just as much care”, says Marianne Nordblom, Director of Gastronomy and Food Development at Fazer Food Services Finland. Food matters for the brain “Brain well-being is important at all stages of life. Children and students of all ages expend a lot of energy on learning. New tools and large amounts of new information put a lot of pressure on the brains of people of working age as well. The population in Finland is aging, and older people also want to enjoy life to the full. Eating the right things helps the brain to get more out of the day”, says Marianne Nordblom. Food matters for the well-being of the brain. In addition to food, the overall brain health of the brain is affected by sleep, exercise and mental well-being.  Fazer Brainhow explores and develops brain-friendly foods The Fazer Brainhow research and development programme takes a holistic approach to brain health. Fazer’s aim with the Brainhow programme is to increase science-based understanding of the effects of food, sleep and mental and physical activity on well-being. Fazer Brainhow explores and develops brain-friendly foods that contain the nutrients our brains need for proper cognitive function. These foods include vegetables, root vegetables, fish, seeds and nuts, fruits and berries, wholegrain products, and cocoa. The brain-friendly foods offered in Fazer Food Services’ restaurant campaign have been planned as part of a healthy diet in accordance with nutrition recommendations. Natural ingredients have been chosen to be as sustainable as possible and good for the environment, and to support the right choices for a healthy life. They are made from ingredients that provide vitamins, minerals, and good fats, but contain only moderate amounts of salt and hard fats. “Every day our personnel restaurants offer one Brainhow lunch option and a variety of Brainhow snacks. We are working to provide healthy alternatives for healthy people in Finland, and great taste is always the most important part of our product development”, says Marianne Nordblom. Fazer’s role in people’s everyday lives provides an opportunity to explore eating habits and encourage people to make healthy choices. Fazer Food Services has 600 restaurants throughout Finland, where we provide a total of 130,000 lunches every day to schoolgoers, working people and seniors. The cornerstones of our product development are well-being, responsibility and gastronomy. Read moreFazer’s Brainhow research programme: http://www.fazergroup.com/brainhow Fazer Brainhow in Amica restaurants: www.amica.fiIn Fazer Brainhow Fazer Food & Co restaurants www.fazerfoodco.fi Further information Marianne Nordblom, Director of Gastronomy and Food Development, Fazer Food Services Finland, tel. +358 400 605,778 Fazer’s media phone line is open Mon–Fri from 8 am to 4 pm, tel. +358 40 668 2998 Emails are in the form firstname.lastname@fazer.com (etunimi.sukunimi@fazer.com) #fazerbrainhow, #ruokaajollaonmerkitys, #fazerfoodservices, #ratkaisujaruuasta

Kindred and Betfilter launch new social responsibility tool for gambling

Kindred Group (previously Unibet Group) have teamed up with Betfilter, who provide a tool blocking access to online gambling sites, to help prevent people under the age of 18 from being exposed to gambling advertisements. Kindred has worked with Betfilter over the past year to help fund the development of the new social responsibility tool called AdBlocker, which will be available across all markets. It is well-known that children under the age of 18 spend a lot of time using mobile devices, tablets and computers, and therefore are susceptible to online gambling ads. This new tool can be installed on all devices where the user wants gambling ads to be blocked. “I am happy that this new social responsibility tool is now ready and available to those who need it. We have always been very clear that our products are only to be used by adults over the age of 18, and therefore see this tool as an important addition to our responsible gambling toolbox. This project also follows our commitment to supply a joyful form of entertainment to our customers”, says Maris Bonello, Integrity Analyst Manager at Kindred Group. “At betfilter.com we are proud to collaborate with Kindred Group on this project. Our company has always strived to help people with gambling problems and also ensure safety for children” says Per Albertsen from Betfilter. “The new AdBlocker, which is initially available for Windows users, blocks gambling ads, thus preventing vulnerable people from being tempted. We believe this Out of Sight, Out of Mind method to be truly effective in promoting responsible gambling”. Kindred will offer a number of AdBlocker licenses for free to customers. The Betfilter license is already offered for free to Kindred customers.

New CEO for Precise Biometrics appointed

”With Stefan’s strong business background and proven leadership skills, the Board of Directors has found a very suitable leader for the next phase in the company’s development. Precise Biometrics will further intensify its efforts to increase biometric usage, and Stefan with his long experience from business development in tech companies and extensive experience from China is the right person to lead the company into the next phase”, says Torgny Hellström, Executive Chairman of the Board of Directors.“I am very pleased to be part of Precise Biometrics future journey and drive the company to the next level. Biometrics is an extremely interesting area and there are many opportunities for us to be part of the growth in this business. We will see many more applications and areas where biometrics will play a decisive role for identification. I’m looking forward to start with the team as soon as possible”, says Stefan K Persson.”Håkan has during his time as CEO reshaped Precise Biometrics to a largely new company, and we thank him for his significant contributions”, continues Torgny Hellström.Stefan K Persson has long standing experience from developing tech companies with focus on consumer products. Stefan joins from Bang & Olufsen where he as Chief Operating Officer has renewed the product portfolio, digitized the company and strongly contributed to the company’s improved results. He last had the position as business area manager of BO Home.Before then, Stefan had a long career at Sony Ericsson, as head of accessories, and as head of development in China. Stefan K Persson is also a member of the Board of Directors in Terranet AB.  FOR FURTHER INFORMATION, PLEASE CONTACTTorgny Hellström, Chairman of the BoardTelephone: +46 733 45 13 00E-mail: torgny.hellstrom@precisebiometrics.com (hakan.persson@precisebiometrics.com) ABOUT PRECISE BIOMETRICSPrecise Biometrics is a market-leading supplier of solutions for convenient and secure authentication of people’s identity. We develop and sell fingerprint software and mobile smart card readers that provide the market’s best user experience and security. Our solutions are used hundreds of millions of times every day by people all over the world and are marketed together with strong business partners. For more information, please visit https://precisebiometrics.com Follow us on LinkedIn  and Twitter .

Precise BioMatch Embedded deployed in biometric payment card market trial in the USA

The payment card, which can be used for contact and contactless payments (dual-interface), improves the convenience for consumers as there is no need to remember PIN codes to authenticate payments. The authentication is done by placing the finger on the card, making it easier and faster to make payments, benefitting both retailers and consumers. The biometric card can be used in the existing retail infrastructure. The card will be tested among US customers, commencing early 2018 to assess the cardholder experience and the technology of the biometric cards in different retail environments.  “I am pleased that we are part of the first US market trials for biometric dual-interface payment cards from a global provider of payments solutions. The interest in biometric payment cards is high and Precise Biometrics is at the forefront of this area”, said Torgny Hellström, Chairman of the Board of Directors at Precise Biometrics.  For more information about the market trial, please visit http://pressreleases.visa.com/phoenix.zhtml?c=215693&p=irol-newsarticlePR&ID=2326492 and https://corporate.fingerprints.com/en/2018/01/15/fingerprints-collaborates-on-biometric-payment-card-market-trial-in-the-usa/This information is information that Precise Biometrics AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 8.15 CET on January 15, 2018.  FOR FURTHER INFORMATION, PLEASE CONTACTTorgny Hellström, Chairman of the BoardTelephone: +46 733 45 13 00E-mail: torgny.hellstrom@precisebiometrics.com (hakan.persson@precisebiometrics.com) ABOUT PRECISE BIOMETRICSPrecise Biometrics is a market-leading supplier of solutions for convenient and secure authentication of people’s identity. We develop and sell fingerprint software and mobile smart card readers that provide the market’s best user experience and security. Our solutions are used hundreds of millions of times every day by people all over the world and are marketed together with strong business partners. For more information, please visit https://precisebiometrics.com Follow us on LinkedIn  and Twitter .

Moberg Pharma receives favorable outcome from NAD – main competitor to discontinue current marketing

In the spring of 2017, Moberg Pharma filed a challenge to NAD on claims made by Kramer Laboratories, Inc. as for the Original Fungi-Nail Toe & Foot Brand (“Fungi-Nail Toe & Foot”) and Fungi-Nail Nailner. The challenge mainly concerned product packaging, television and print advertising for “Fungi-Nail Toe & Foot”; claiming to treat toenail fungus rather than athlete’s foot which is the approved indication for the product. A more detailed description of NAD’s rationale and conclusion on the challenge is available in a press release from ASRC, please see http://www.asrcreviews.org/nad-refers-advertising-for-fungi-nail-products-to-ftc-for-further-review-after-company-declines-to-comply-with-nad-recommendations/. The press release sets forth NAD’s conclusions: · NAD recommended the advertiser to discontinue the Fungi-Nail Toe & Foot product name and the associated fungal toenail images. · NAD also recommended the Fungi-Nail Toe & Foot product packaging and television commercials to be discontinued or modified to clearly and conspicuously state, in proximity to the main advertising claims, that the product treats athlete’s foot, not toenail fungus. · NAD recommended the advertiser to discontinue all claims that the Fungi-Nail Toe & Foot product works “fast,” kills fungus “on contact,” stops “tough” infections, and is the “#1 Pharmacist Recommended” brand. However, NAD found that there is a reasonable basis for the advertiser’s “stops the spread” (of the skin fungus) claim. · With respect to the advertiser’s Fungi-Nail Nailner product, NAD recommended the image of the fungal toenail, as well as the claims: “Clears nails fast,” “Visible results after seven days,” “Looking to improve nail appearance fast? These cure fungus ugly nails in 48 weeks,” and “Fungus Ugly to Prettier Nails Fast!” to be discontinued. According to NAD, Kramer Laboratories have declared that they will comply with all recommendations except for changing the trade name. As a result, NAD has referred the trade name issue to the attention of the appropriate government agency for possible enforcement action. “We are highly pleased with the outcome from NAD and we expect the outcome to further strengthen Kerasal Nails® position and growth prospects in the U.S. market”, says Peter Wolpert, CEO of Moberg Pharma AB. About this informationMoberg Pharma AB is obliged to make this information public pursuant to the EU Market Abuse Regulation (MAR). The information was submitted for publication, through the agency of the contact person set out above, at 08:30 a.m. (CET) on January 15th, 2018.

Minesto to enhance Deep Green product range and intensify market penetration activities

The preparations in Wales for offshore testing of Minesto's first commercial-scale Deep Green device is now in its final phase. Installation is due to commence in April 2018, with the ambition to generate electricity during the third quarter 2018. This is a key milestone in the overall development of the Deep Green technology and the results will enable customers, project financiers and funding partners to take the next steps in cooperation with Minesto. The performance results generated during Autumn 2017 by Minesto, based on its model-scale ocean testing and analytical simulations, indicates areas where performance can be increased and hence competitiveness in future design iterations. The future global renewable energy mix must consist of a combination of technologies that utilise different natural resources for power generation, to provide the world's population with cost-effective and reliable sources of renewable energy. Minesto's Deep Green concept is such a technology, as it is cost competitive in comparison with fossil energy as well as solar and wind power in parts of the world. Global expansion potential Based on a new internal analysis of university and marine research studies, Minesto estimates that the identified exploitable potential of the company's product exceeds 600 GW installed capacity; three times higher than previous assessments. This translates into a long-term global expansion potential for Minesto’s technology equivalent to one and a half times today's global nuclear power capacity. In addition, predictable and secure base load power generation and non-use of land areas provide further potential economic benefits of Minesto's technology. As a first step towards realising this potential, Minesto intends to enhance the company's product range while intensifying and expanding its activities for market penetration. Enhancement of the product range The combination of dialogue with global energy industry players providing small-scale energy systems (micro grids), customer enquiries and market analysis, has indicated to Minesto that there is a significant customer demand for smaller-scale autonomously operated (“Island Mode”) Deep Green systems. Island Mode installations can be utilised across a wide spectrum of applications from remote industries to entire communities that do not have access to centrally distributed electricity either today or in the future. A smaller Deep Green DG100 unit, with a rated power of up to 100 kW and a 4–5-meter wing span provides Minesto with an additional commercial product that can be supplied into more customer and partner-funded projects, thus cost-effectively opening new tangible markets and business opportunities – in Asia as well as on other continents. Intensified activities for market penetration During the Autumn of 2017, political uncertainty surrounding the United Kingdom’s revenue support mechanism for new renewable energy technologies has arisen. In addition, negotiations on the UK’s exit from the EU have not yet yielded any results related to the marine energy industry in Britain. Minesto's current work in Wales is not affected by this, nor does it affect potential following financial support from the European Regional Development Funds in Wales. However, there are potential for delays to future deployment phases of Holyhead Deep given that the political uncertainties potentially will last for a long time. An alternative revenue support mechanism for the UK marine renewable energy industry has been proposed, but is not yet in place, which complicates project investments in the UK. To mitigate this uncertainty, and to take advantage of identified business opportunities, Minesto intends to intensify and broaden its activities for market penetration to three geographical markets: 1. The ongoing development in Wales. The first phase of the project, to commence commercial-scale electricity production with DG500, is a crucial milestone to Minesto. Scope and content for the next step in the development of Holyhead Deep will be adapted to the political environment that will be formed in 2018. The long-term goal of expanding the Holyhead Deep site into an 80 MW array remains. 2. Site development within the post-Brexit EU to build on and capitalise on developments in Wales. This initiative aims to ensure full access to the EU's ambitious support structures for the expansion of renewable marine energy. By collaborating with the company's current supply chain, project developers within the EU and Minesto's investor InnoEnergy (owned by European utilities), Minesto estimates the conditions for commercial breakthrough in this market to be good.  3. Intensified activities in Taiwan to establish a tidal stream site in Keelung and a first installation in ocean currents. Share Rights Issue The Share Rights Issue, proposed by Minesto’s Board of Directors and announced on December 22, 2017, aims to: · Ensure the successful completion of the first installation and demonstration of the Deep Green technology in Holyhead Deep. · Strengthen and expand Minesto's commercial ability to ensure the fastest path to a commercial breakthrough. Accordingly, the funds raised are planned to be used mainly for: · Installation, testing and demonstration at Holyhead Deep, Wales. · Enhancement of the product range. · Site development and activities for market penetration in the UK, EU and Taiwan. For a more detailed description of Minesto's operations and details of the Share Rights Issue, please refer to Minesto's website www.minesto.com and the Swedish prospectus, which is expected to be published around 25 January. For additional information please contact: Dr Martin EdlundCEO, Minesto AB+46 31 29 00 60press@minesto.com  Magnus MatssonCommunications Manager, Minesto AB+46 70 570 75 08press@minesto.com About Minesto Minesto is a marine energy technology company with the mission to minimise the global carbon footprint of the energy industry by enabling commercial power production from the ocean. Minesto’s award winning and patented product, Deep Green, is the only verified marine power plant that operates cost efficiently in areas with low-flow tidal streams and ocean currents. In May 2015, Minesto secured a €13m investment from the European Regional Development Fund through the Welsh European Funding Office, for the commercial rollout of Deep Green. Minesto was founded in 2007 and has offices in Gothenburg, Sweden, Holyhead, Wales and Portaferry, Northern Ireland. The major shareholders in Minesto are BGA Invest and Midroc New Technology. The Minesto share (MINEST) is traded on the Nasdaq First North Stockholm stock exchange, with G&W Fondkommission as Certified Adviser. Read more about Minesto at www.minesto.com Press images and other media material is available for download via bit.ly/minestomedia. The information in this press release is such that Minesto AB (publ) shall announce publicly according to the EU Regulation No 596/2014 on market abuse (MAR). The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on 15 January 2018.

Pontus Willquist new VP SMB & B2C

Pontus most recent position was as Head of Pricing and Analytics at Dustin and before that, he was responsible for the company’s online sales. He has worked at Dustin for almost eight years. Previously, Pontus has also been Head of business development at e-tailer Brandos. - Pontus has great knowledge of Dustin and our customers’ needs as well as solid experience from work with our online affair. He will therefore be the right person to lead the work to continue to develop our online platform and meet the demands from our core target group of small and medium-sized businesses. I would also like to thank Göran. During his ten years at Dustin he has built a strong team and has contributed to develop the company to one of the leading Nordic e-tailers, says Thomas Ekman, CEO of Dustin. Pontus Willquist starts his new position at the latest on 1st of May. - I have had the privilege of working in several part of Dustin’s business and I look forward to continue to be a part of the development of our business so that we can best assist our customers with their IT challenges, says Pontus Willquist. Göran Lindö started at Dustin in 2007. For further information, please contact:   Eva Ernfors, Head of Information: eva.ernfors@dustin.se, +46 70 258 62 94 About Dustin Dustin is one of the leading Nordic resellers of IT products with associated services to companies, the public sector and private individuals. With its core business in e-commerce, Dustin functions as a bridge between the manufacturer’s wide-ranging offerings and customer requirements, in which Dustin’s employees support customers in finding the appropriate solution for them. Dustin is a one-stop-shop that offers some 250,000 products with associated services, features and solutions. Operations are conducted in Sweden, Denmark, Norway and Finland. The company has approximately 1 000 employees. Sales during the 2016/17 financial year amounted to approximately SEK 9.3 billion. About 90 per cent of Dustin’s income derives from the corporate market with a focus on small and medium-sized companies. Dustin Group has been listed on Nasdaq Stockholm since 2015 and has its head office in Nacka, Stockholm.

Bayn Europe is setting up a subsidiary in China for sugar reduction

Both partners agreed on a cooperation model and mutual commitments for the set up of joint venture. Bayn will hold 65% of equity and HuaHe will hold 35%. Further to rolling up a sugar reduced concept store under Bayn Europe’s trademark takk!, Bayn China have ongoing discussions regarding a sugar reduced industry park with Chinese government stakeholders. “Sugar reduction means a system change and the food chain is broken when the added sugar is replaced. This is also true for the Chinese market, despite having 110 million diabetics and a very large child obesity problem due to unhealthy lifestyles with excess sugar consumption”, says Lucy Dahlgren, CEO of Bayn Europe. “We are glad to now have a strategic agreement with a partner, outside the food system, who pursues the real need for sugar reduction.  The first showcase of takk! concept store is planned to open before this summer, and it will be launched as a franchising concept in this fall. We have dialogues with several investment partners and plan to set up 200 takk! stores by 2022.” “We are glad to have Bayn who has brought us a totally new concept to our property customers. Particularly to government stakeholders who want to develop their cities in a sustainable manner”, says Dr. Henry Yang, General Manager of HuaHe. “We, as lifestyle architects in real estate and the property industry, believe that the opportunities arising out of the synergies between our two companies are very promising.” About Huahe Huahe International (Beijing) Assets Management Consulting Co., Ltd (hereinafter referred to as Huahe International) is a holding subsidiary of Hede Holdings, which is in charge of assets management and equity investment businesses. Huahe International is supported by Hede Holdings in the fields of business and health care of service capability and resources integration in whole product chain. Huahe International, cooperated with three subsidiaries (Haskoll Design, Hede Consultancy and Hede Construction), provides whole product chain service of all-round strategic positioning, planning consultancy, industry introduction, integrated design, project and construction management, assets management and operation, equity investment, etc for Chinese commerce and health care fields. About Bayn Europe Bayn Europe is an independent formulation developer of cutting edge and healthy sugar reduction solutions for the food and beverage industry. Bayn’s total solutions focus on taste, texture and cost-in-use. Bayn’s product portfolio contains ingredients and sugar replacers for food and beverage applications. Bayn’s business model is based on solid networks of scientific research, market channel partnerships and contracted manufacturers. Bayn Europe was founded in 2009 in Stockholm, Sweden, and is listed at Nasdaq Stockholm, First North, since 2014. Mangold Fondkommission AB is Bayn’s certified adviser. Telephone +46-8-5030 1550. For more information, please contact Lucy Dahlgren, Managing Director Bayn Europe AB, e-mail ld@bayn.se Denna information är sådan information som Bayn Europe AB är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning. Informationen lämnades, genom ovanstående kontaktpersons försorg, för offentliggörande den 15 jan 2018 kl. 09.00 CET.

A new way of building

The Naantali NA4 CHP power plant was constructed with co-operative innovation. The multi-fuel power plant NA4 CHP in Naantali is the first industrial project to apply the alliance model in its construction work. When the power plant was opened at the beginning of December, the parties of the alliance had good reason to be satisfied. All the objectives of the construction project were fulfilled: it was finished in schedule, the costs remained under the estimate and the results were of excellent quality. Occupational safety was also at a very high level throughout the project. During the 1.4 million working hours, only three minor occupational accidents occurred that led to absence from work. “The project has reached its goal. Not through luck but rather through success,” sums up Tapani Bastman, President and CEO of Turun Seudun Energiantuotanto.  He admits feeling relieved now that the plant has been opened.  The most significant part, i.e. the new multi-fuel power plant, is completed, its boiler was tested and it is deemed functional. “Our objective was to build a flexible, modern, state-of-the-art power plant with a 40-year service life. That objective has now been fulfilled,” says Bastman. Bastman found the construction work implemented with the alliance model interesting. “In major industrial construction projects, the situation of having several contractors on site at the same time is inevitable. Lack of communication increases loss. Everything must function smoothly without any arm-wrestling about the division of labour,” he says. Timo Tuomisto, the alliance Project Manager from YIT, is happy that the Naantali project was constructed using a co-operative contracting format. “We certainly worked together in this project, making sure we had a mutual understanding about everything. This was evident in all our operations,” he says. Casting the divided model aside Anne Piiparinen from YIT is also more than satisfied. She feels that constructing the CHP power plant in Naantali with the alliance model was a significant decision for the entire business segment. “This example shows that an industrial construction project can also be implemented using the alliance model. This enables us to let go of the traditional, divided construction model and implement projects with genuine co-operation,” she says. She finds the alliance a great way of implementing similar, challenging projects. The fact that this project fulfilled all its objectives proves the extremely high-quality project management which has been greatly supported by the alliance model. “When the objectives are met at a high level in a major project, it indicates that the method of execution was correct.” According to Piiparinen, the alliance model can help tackle the most essential problem in a traditional construction project: “The traditional method contains a vast number of agreement interfaces that easily create differences of interest. In the alliance model, the shared objectives sought by all the parties are thoroughly considered and planned. This has proved to be quite fruitful,” says Piiparinen. Heikki Jaakkola from Fortum agrees. “The positive new aspect of the alliance model is the co-operation. The model aims to a higher number of interest shared by all. Even in the alliance model, the deliver chains are long as required by the current situation, and managing the subcontracting chains is challenging, but the alliance model will make it easier on site when working together,” he says. According to Tuomisto, the development stage of an alliance project may seem long, but when the path is designed well, it pays off. “The development stage of this project took several months. However, the good plan was worth it. As the old saying goes, well begun is half done.” Learning to understand the other party Jaakkola states that the alliance model gave him a more in-depth understanding of construction. “The model both makes and enables you to get more deeply involved in the implementation of the actual construction and building systems. Each party obviously manages their own part, but I have to admit that this project taught me to understand the construction perspective much better,” he says. Anne Piiparinen points out the innovation introduced by the alliance model. “For me, the most important lesson from this project was that close co-operation is the best way to make the most out of a team’s competence. In the Naantali construction project, this idea was introduced at all levels,” says Piiparinen. The best manifestation of this, according to Piiparinen, is the project’s innovation system that truly sparked great ideas. “When the innovation was managed in a systematic manner and the employees realised that their innovations were being heard, it was as if a bottle was uncorked. Ideas big and small started to gush out as well as innovations that actually resulted in cost savings, improved level of safety and ensured quality of the end result.” During the project, more than 100 ideas were adopted, and the innovations created in the project were one of the major factors in winning the Construction Site of the Year 2016 competition. “I think this shows that each person is interested in developing their work as long as they are given the chance,” says Piiparinen. Tuomisto agrees that inspiring people to innovate was the best lesson from the Naantali construction project. “Ideas truly came from all sides. The alliance provided the groundwork for processing all these ideas. When the rewarding system was in use and covered all parties, everyone was inspired to come up with ideas,” he says. Tuomisto believes that, in the future, cooperation will be the standard method in all construction projects. “When looking back at this project, I must say it would’ve been great to have this model in use earlier. That’s how well the alliance model works,” says Tuomisto. NA4 CHP · The multi-fuel power plant in Naantali produces electricity and heat · The plant will partly replace three coal-fuelled power plant units that have been in operation for approximately 50 years. · The main objective is to increase the use of renewable energy. · The construction work was carried out with the POLTE alliance, comprising Turun Seudun Energiantuotanto Oy, YIT Construction Ltd, A-insinöörit Suunnittelu Oy and Insinööritoimisto Ax LVI Oy. · The first industry alliance to win the Construction Site of the Year 2016 competition. For further information, please contact: Anne Piiparinen, Vice President, YIT Construction Ltd, tel. +358 (0)40 823 2808, anne.piiparinen@yit.fi Hanna Malmivaara, Vice President, Communications, YIT Corporation, tel. +358 (0)40 561 6568, hanna.malmivaara@yit.fi YIT creates a better living environment by developing and constructing housing, business premises, infrastructure and entire areas. Our vision is to bring more life into sustainable cities. We want to focus on caring for customers, visionary urban development, passionate execution and inspiring leadership. Our growth engine is urban development involving partners. Our operating area covers Finland, Russia, the Baltic countries, the Czech Republic, Slovakia and Poland. In 2016, our revenue amounted to nearly EUR 1.8 billion, and we employ about 5,300 employees. Our share is listed on Nasdaq Helsinki. www.yitgroup.com  

Getinge announces date of 2017 Year End Report and Conference Call

Fund managers, analysts and the media are invited to participate in the conference call. Please see dial in details below to join the conference: Sweden:         +46 (0)8 5033 6574               UK:                +44 (0)330 336 9105US:                +1 323-794-2093Code:             9815129 During the telephone conference a presentation will be held. To access the presentation through webcast, please use this link: https://slideassist.webcasts.com/starthere.jsp?ei=1176385 Alternatively, use the following link to download the presentation: https://www.getinge.com/int/about-us/investors/reports-presentations Agenda09:45              Call in to the conference10:00              Review of the Year End report10:30              Q&A11:00              End of conference Recording available for 90 daysA recorded version of the conference can be accessed for 90 days via the following link: https://slideassist.webcasts.com/starthere.jsp?ei=1176385 For more information, please contactLars Mattsson, Head of Investor RelationsPhone:           +46(0)10 335 0043E-mail:            lars.mattsson@getinge.com About GetingeGetinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the every-day life for people, today and tomorrow.www.getinge.com

Best Buy completes previously announced* initial 60 store Electronic Shelf Label (ESL) Deployment with Pricer

Best Buy, a leading consumer electronics retailer with more than 1,000 large-format stores in the United States, selected Pricer for the supply of Electronic Shelf-Edge solutions and completed an initial 60-store deployment prior to its holiday shopping season.“In a shopping environment where more and more customers shop both online and in physical stores, having the ability to quickly update prices in our stores is very important,” said Nicole Nelson, Vice President of Pricing at Best Buy. “Having electronic shelf labels in place allows employees to focus on serving customers instead of changing paper price tags. In addition, the labels allow our store employees to – at a glance - get important real-time information like inventory.“This has been a very exciting process,” says Gary Glaser, Director at Pricer Inc. “Best Buy is clearly paving the way for digital transformation, pushing our organization to enhance our hardware and software solutions to meet their unique requirements and ambitions.”“This decision is of significant value for our US market position, giving us privileged insight and understanding as major retailers align their business goals with new technologies”, says Charles Jackson, President of Pricer Inc. “We want to thank Best Buy for their confidence in our capabilities to support their investments in revolutionizing the customer experience and the omnichannel approach.” For further information, please contact:Donald Charles Jackson, President Pricer, Inc., or Helena Holmgren, acting CEO, Pricer AB, +46 8 505 582 00* This press release refers to Pricer’s press release with headline ‘Leading US Retailer chooses Pricer’s Digital Shelf-edge solutions’ that was published on July 14, 2017.Pricer, founded in 1991 in Uppsala, Sweden, is the global leader in providing in-store shelf-edge digital solutions that enhance both store performance and the shopping experience. Pricer AB (publ) is quoted on the Small Cap list of Nasdaq Stockholm. For further information, please visit www.pricer.com.

Solteq Plc – Directed share issue to Theilgaard Mortensen Holding ApS

Solteq Plc Stock Exchange Bulletin 15.1.2018 at 14.00 pm Solteq Plc’s Board of Directors decided today to carry out a directed share issue in kind of 628.930 shares to Theilgaard Mortensen Holding ApS in order to execute the acquisition of the share capital of TM United A/S. The decision on the directed share issue and deviation from the shareholders’ pre-emptive subscription rights was made based on the authorisation granted by the Annual General Meeting of 17 March 2017. The purchase is an essential part of the strategy related to expansion of company’s business in Denmark and other Nordic countries in accordance with the Company’s strategy published on 25 May 2015. Therefore, there is a weighty financial reason for deviation from the pre-emptive subscription right of shareholders in accordance with chapter 9, section 4, subsection 1 of the Company’s Act (624/2016, including amendments). The subscription price of shares to be given is 1.59 Euros per share. The determination of the subscription price is based on the share’s trading-volume-weighted closing rate average in the NASDAQ OMX Helsinki between 25 October 2017 - 24 November 2017. The subscription price of 628,930 shares to be given in the directed share issue, in total 999,998.70 Euros, shall be paid fully by the property given as contribution in kind, which comprise of 520,300 shares in TM United A/S. In addition to the shares given through the directed issue, cash shall be paid in accordance with the share purchase agreement as contribution for shares to be received as contribution in kind. The share issue will be carried out by issuing new shares that will carry full rights after they are registered in the Trade Register. After the registration, admission to trading will be sought for the shares. Theilgaard Mortensen Holding ApS has today subscribed for all the shares offered. The subscription price shall be recorded in its entirety to the invested non-restricted equity fund of the company. The issued shares represent 3.26 percent of the post-issue outstanding shares. After the changes, the total number of the company’s shares is 19,306,527. Further information Olli Väätäinen, CEOtel. +358 50 5578 111e-mail olli.vaatainen@solteq.com Antti Kärkkäinen, CFOtel. +358 40 8444 393e-mail antti.karkkainen@solteq.com Distribution NASDAQ OMXHelsinki Major mediawww.solteq.com Solteq in Brief Solteq is a Nordic IT provider and software house that specialises in digital customer engagement. Our mission is to simplify the digital world to make better tomorrow. We are a partner who knows how to turn the digital disruption for the benefit of our customer. Our over 500 experts, who work in three countries, develop and implement solutions for clients in Nordic countries as well as Europe, North America, Asia and Australia. In 2016, Solteq’s net sales amounted to 63 million euro.

Metsä Board Corporation: Managers’ transactions

Member of the Board of Metsä Board, Ms Liisa Leino has inherited the Company’s shares as follows: +-------------------+-------------+---------------------------------------+|Manager within the |Liisa Leino ||issuer: | |+-------------------+-------------+---------------------------------------+|Manager’s   |Member of the Board ||position within the| ||issuer: | |+-------------------+-------------+---------------------------------------+|The issuer: |Metsä Board Corporation |+-------------------+-------------+---------------------------------------+|Issuer’s LEI-code: |743700KKB8Q035K38488 |+-------------------+-------------+---------------------------------------+|Notification type: |Initial notification |+-------------------+-------------+---------------------------------------+|Reference number: |743700KKB8Q035K38488_20180115123301_9 |+-------------------+-------------+---------------------------------------+|Transaction date: |14 June 2017 |+-------------------+-------------+---------------------------------------+|Nature of the   |GIFT, DONATION OR INHERITANCE (RECEIVED) ||transaction:   | |+-------------------+-------------+---------------------------------------+|Instrument type:  |SHARE |+-------------------+-------------+---------------------------------------+|Instrument’s name: |Metsä Board B share |+-------------------+-------------+---------------------------------------+|Instrument’s ISIN |FI0009000665 ||-code: | |+-------------------+-------------+---------------------------------------+|Transaction |Volume: 6,000|Unit price: EUR 6.69 ||details: | | |+-------------------+-------------+---------------------------------------+|Number   of |1 ||transactions:  | |+-------------------+-------------+---------------------------------------+|Aggregated |Volume: 6,000|Volume weighted average price: EUR 6.69||transactions: | | |+-------------------+-------------+---------------------------------------+ METSÄ BOARD CORPORATION

Artificial Intelligence and Machine Learning Add a New Level of Possibilities in Navetti PricePoint™ Price Optimization Solutions

Advanced machine learning and analytical methods can be applied across all stages in the pricing waterfall, from centrally defined pricing strategies to locally adjusted specific executions for individual customer orders. It means that the system can be customized to individual client needs faster and reduces time to market for new features and developments, and Navetti is working with a range of blue-chip clients to develop customer-specific price optimization solutions. By applying these facilities across the different modules in Navetti PricePoint™, Navetti helps its customers understand, optimize and capture additional business opportunities through more precise pricing structures, more efficient internal handling and more predictable business outcomes.  Pricing and price optimization is already a big data business application, taking in and analysing millions of different data points from all aspects of the business environment, such as product specification details, transactional data (who bought what, when, where and how), supply chain situations, competitive environment and channel-specific conditions. Hence, it is no surprise that price optimization systems increasingly are applying advanced algorithms and machine learning capabilities to further enhance system capacity and capabilities. “Many vendors talk about Artificial Intelligence and Machine Learning (AI & ML) as an add-on to their legacy systems”, says Andreas Westling, CEO of Navetti. “For us at Navetti, this kind of advanced adaptive intelligence has been a key perspective in our development of our solutions for a long time. Our Navetti PricePoint™ platform and its optimization algorithms have been designed to incorporate applied artificial intelligence and machine learning ever since we started to develop the fourth generation of Navetti PricePoint™. A key difference is that we apply AI & ML across the entire pricing waterfall, which means our customers can use this to improve all stages of the customer journey. Now we are taking the next step by making AI & ML a general engine for all pricing processes and their corresponding modules in Navetti PricePoint™, and we have already started to apply this together with several major clients when developing customer-specific solutions for both e-commerce and traditional manufacturing applications. In this way, we are offering our customers the best of two worlds: a fully developed off-the-shelf system that can be configured to our customer’s specifications, fully integrated and implemented in a matter of weeks, and an AI & ML engine for rapid additional developments. In addition, we expect AI & ML developments to take place across many other aspects of our customers’ businesses, and hence we have made sure that Navetti PricePoint™ can easily interact and be fully integrated with the AI & ML structures in other parts of our client’s IT solutions.” “Price optimization is not just about the actual price itself”, Westling continues. “But AI & ML usually starts by methods of recording and learning how different customers respond to different pricing strategies in different situations. By using machine learning techniques like logical inference, neural networks and heuristic search, we can align, adjust and optimize not just the specific price itself but the full customer purchasing experience to suit the transaction process, which has a positive impact on our client’s business objectives. However, most business situations are more complex than that, and hence we are also applying AI & ML in decision processes.” These include - Virtual product family creation and market segmentation, i.e. understanding which products and market segments are similar, and how these clusters differ from each other in terms of customer behaviour. - Customer value attribution, i.e. understanding how different features and product attributes generate value for different types of customers and market situations. - Deeper business logic understanding, i.e. understanding how complementary attributes such as competitive structures, customer support, supplier terms and conditions and supply mechanisms influence the pricing mechanics, and how these jointly help define both the optimum price and the total business impact. - Advanced demand forecasting, i.e. taking the price optimization results and applying them in the supply chain mechanism, allowing suppliers to balance their inventory and production cycles against expected demand levels. We know that when customers plan and implement price optimization systems, they look at three different benefits: - Sales and margin growth opportunity, i.e. identifying and turning business opportunities to bottom line results through market-driven and customer value-based price optimization. - Risk reduction, i.e. companies under pressure from customers and/or competitors with price harmonization needs use professional pricing systems to support them in their pricing logic and operational pricing activities to both reduce risks such as cross-border trading and improve perceived quality. - Operational efficiency, i.e.  the ability to take pricing decisions faster and more efficiently throughout the organization. “With artificial intelligence and machine learning across the entire Navetti PricePoint™ system structure, we are helping customers use price optimization logic across the business operations, with a considerable impact across all three benefit dimensions,” Westling concludes.

OmniByte joins IFS Partner Network to Resell and Implement Field Service Management Software

OmniByte will act as a channel partner to sell and implement IFS Field Service Management  and IFS Planning and Scheduling Optimization  (IFS’s dynamic scheduling engine) to the broader specialty contractor vertical. IFS and OmniByte are already actively engaged in joint go-to-market and customer implementation activites. “In the market OmniByte serves, we see a lack of good, ERP-agnostic field service management applications,” OmniByte Chief Marketing Officer Mike Neuser said. “Some solutions are under-developed and very constrained in their functional scope, lack a highly configurable and scalable work force mobile solution and aren’t keeping pace with emerging technologies. Others are nearing the end of their lifecycle and are becoming burning platforms. We see IFS Field Service Management as the strongest offering on the market today, with complete and powerful industry functionality, including a dynamic scheduling engine, a strong mobile solution, an IoT business connector, a considerable investment in R&D, and a history of successful integrations with a broad spectrum of ERP systems. Many customers don’t need a new ERP system. They just need a game changing and compelling field service management solution.” IFS Director of Partner Alliances for North America Parker Zanios added, “The team at OmniByte exemplifies what we look for in a partner organization. They bring documented domain-specific knowledge and are well-respected in the markets they serve. They are trained in our solutions and implementation methodology, but we expect to learn quite a bit from them as well. We have confidence in their abilities and commitment to growing the family of companies running IFS Field Service Management.” More information about IFS Field Service Management can be found here: http://www.ifsworld.com/us/solutions/service-management/field-service-management/.

Fritz Schur is stepping down as Chairman and as a member of the Board of SAS from the 2018 Annual General Meeting

Fritz Schur has been a member of the Board of SAS AB since 2001 and its Chairman since 2008. “In my time on the Board, SAS has undergone a total transformation. Above all, cost levels have declined significantly, which has enabled SAS to lower ticket prices. This has lead to considerably improved competitiveness. After a number of years with negative earnings, for the third consecutive year, SAS has posted billion-krona earnings and, moreover, recently delivered its best results for 20 years. With Rickard Gustafson and his team, SAS has a highly qualified management team and given the expectations for 2018, this is an appropriate moment to change Chairman,” says Fritz Schur. Fritz Schur has already given the Nomination Committee notice to enable the search for a new Chairman to commence. SAS President and CEO Rickard Gustafson is grateful for Fritz Schur’s considerable contribution to SAS. “During Fritz Schur’s time as Chairman, SAS has undergone a major transformation to meet increased global competition. Operations have been fundamentally changed, from the destinations offered, the customer offering and the cost structure to production platforms and the aircraft fleet. Fritz Schur’s chairmanship and his considerable commitment have been decisive in this change process and key to bringing about SAS’s current position, where the company can look forward and further strengthen its position as the natural choice for all passengers who need to travel to, from and within Scandinavia,” says Rickard Gustafson. “It has been both important and challenging to participate in rebuilding a strong SAS, and I would like to thank the state shareholders, Board colleagues, and SAS’s management and employees for a rewarding partnership. SAS is an icon for Scandinavian commerce, and I consider, and always have done, SAS to be an extremely important Scandinavian business and one that cannot be allowed to just fade away. I wish the company the very best on its continued journey,” concludes Fritz Schur. The AGM of SAS is planned to be held on March 5, 2018.

STARBREEZE brings iNK Stories Virtual Reality experience “HERO” to the 2018 Sundance Film Festival January 18-28

Starbreeze AB, an independent creator publisher and distributor of high quality entertainment products, together with iNK Stories, will premiere the Vérité VR Experience HERO as a part of Sundance Institute New Frontier initiative. HERO will be featured during the festival January 18-28 at the Kimball Art Center in Park City, UT. HERO comes from the award-winning studio iNK Stories that brought us 1979 REVOLUTION: Black Friday. iNK Stories, in partnership with Starbreeze Studios, have created an immersive, large-scale installation that explores humanity in our modern era of civilian warfare. When the world around you is shattered and you hear the cries for help, what do you do? Put on the headset and ask yourself – What does it really mean to be a Hero? A Verite VR experience, HERO blends interactivity with a Cinema Verite documentary approach to create a groundbreaking immersive experience. Featuring physical sensations of touch, deep and powerful audioscape, vivid environmental effects, and more - HERO gives audiences a full sensory experience. iNk Stories and Starbreeze are excited to premiere this new format of storytelling with the world. Hero also includes groundbreaking sound design utilizing DTSX object-based audio from Xperi  and realized with 30 speakers, subwoofers and advanced playback from QSC. The collaboration with DTS and Starbreeze redefines a location-based VR experience and takes experiential storytelling to a whole new level. Sundance Institute showcases a curated collection of cutting-edge independent experimental media works by creators who are pushing the artistic development of the new mediums of VR, AR, mixed reality (MR) and AI. The 2018 edition of New Frontier at the Sundance Film Festival offers some of the most innovative independent production and experimentation at the crossroads of film, art and technology that is being created today. HERO is part of Starbreeze Virtual Reality (VR) experiences produced under its Publishing arm to be produced for future Location Based Initiatives (LBE) in the StarVR Virtual Reality HMD. Each experience aims to push the bar far beyond what’s possible in-home use setups. ### Download the latest Starbreeze press assets here: http://www.starbreeze.com/presskit  For appointments and press requests at Sundance:Brooks Brown, Global Director of VRTel: (310) 795-7288, email: brooks.brown@starbreeze.com  For more information on iNK Stories, please contact:Andres Perez-Duarte, PartnerTel: (917.675.9624), email: andres@inkstories.com For more information, please contact:Maeva Sponbergs, EVP CommunicationTel: +46(0)8-209 208, email: press@starbreeze.com (ir@starbreeze.com) 

Preliminary revenues and operating profit for NetEnt in the fourth quarter of 2017

The difference between market estimates and the preliminary operating profit of NetEnt in the fourth quarter 2017 is due to lower-than-expected revenue growth. During 2017, NetEnt phased out deliveries of games to operators in Australia, Poland and Czech Republic. In the fourth quarter, this had a negative effect on revenue growth of around three percentage points. Further, underlying revenue growth in some of NetEnt’s markets was lower than expected in the quarter. NetEnt’s business continued to generate a solid cash flow in the fourth quarter and the dividend for 2017 will be at least in line with 2016 year’s level. A telephone conference will be held today at 9:30 a.m. (CET) with NetEnt’s President and CEO Per Eriksson and Therese Hillman, CFO. To participate in the telephone conference, with the possibility to ask questions, please dial:UK: +44 20 30089801SE: +46 8 56642662The conference call will also be available on the web, the link is https://tv.streamfabriken.com/2018-01-16-pressconference The financial figures presented above are preliminary. The earnings report for the fourth quarter and full year 2017 will be released as planned on February 15th, 2018 at 7.30 a.m. (CET). For additional information please contact:Per Eriksson, President and CEO of NetEntPhone: +46 8 5785 4500per.eriksson@netent.com Therese Hillman, CFO of NetEntPhone: +46 8 5785 4500therese.hillman@netent.com Roland Glasfors, Investor Relations, NetEntPhone +46 760 024 863roland.glasfors@netent.com This information is information that NetEnt AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:30 CET on January 16th, 2018. About NetEntNetEnt AB (publ) is a leading digital entertainment company, providing premium gaming solutions to the world’s most successful online casino operators. Since its inception in 1996, NetEnt has been a true pioneer in driving the market with thrilling games powered by a cutting-edge platform. NetEnt is committed to helping customers stay ahead of the competition, is listed on NASDAQ Stockholm (NET–B) and employs more than 900 people in Stockholm, Malta, Kiev, Krakow, Gothenburg, Gibraltar and New Jersey. www.netent.com

Scandic predicts lower earnings for the fourth quarter

Scandic Hotels estimates that adjusted EBITDA for the fourth quarter 2017 will be around 330 MSEK. For the fourth quarter of 2016 adjusted EBITDA amounted to 392 MSEK adjusted for a one-off gain of 65 MSEK. The deviation is explained by lower earnings in the Swedish operations and one-time costs for central functions. Earnings development in Norway and Other Nordics & Europe have remained positive during the quarter. Scandic estimates that adjusted EBITDA for the Swedish operations will be approximately 200 MSEK for the fourth quarter compared with 264 MSEK in the fourth quarter of the previous year, adjusted for a one-off gain of 65 MSEK. The decline in earnings is primarily attributable to operations in Stockholm where the market was weak in the quarter, and costs were not fully adjusted in line with the weaker LFL sales development. Adjusted EBITDA for Scandic Hotels’ central functions is estimated to amount to approximately -140 MSEK for the fourth quarter compared with -103 MSEK for the corresponding period in 2016. The variance is mainly due to a number of one-time items. The result includes, among other things, costs for Scandic’s long-term incentive programs and other non-recurring personnel costs. Earnings figures are preliminary and have not been reviewed by the company's auditor. Scandic Hotels will publish its Year-end Report for 2017 on 20 February at 07:30 CET. For more information, please contact:Even Frydenberg, President & CEOPhone: +46 8 173 50 00 Jan Johansson, Chief Financial OfficerEmail: jan.johansson@scandichotels.comPhone: +46 70 575 89 72 Henrik Vikström, Director Investor RelationsEmail: henrik.vikstrom@scandichotels.comPhone: +46 709 52 80 06 This information is information that Scandic Hotels Group AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07.30 CET on 16 January. About Scandic                                                                                                                      Scandic is the largest hotel company in the Nordic region with 15,000 team members and a network of close to 230 hotels with about 45,000 hotel rooms in operation and under development. Scandic Friends is the biggest loyalty program in the Nordic hotel sector with 2 million members. Corporate responsibility has always been a part of Scandic’s DNA and Scandic has been named Best Hotel Brand in the Nordic countries (BDRC). Since December 2, 2015, Scandic has been listed on Nasdaq Stockholm. www.scandichotelsgroup.com   

RayStation selected for new Carbon ion therapy center in Japan

RayStation* has been chosen as the treatment planning system for a new carbon-ion therapy facility which is under construction at Yamagata University Hospital in northern Japan. The order represents the first RayStation carbon ion installation in Japan. Carbon ion therapy is an advanced form of radiation therapy that precisely targets cancer cells with minimal damage to surrounding tissue. The technique uses a carbon ion beam, accelerated up to 70% of the speed of light. Carbon ion beams are highly effective in destroying cancer cells, and the technique can be effective for cancers that are resistant to X-rays. An additional advantage is that the treatment period often is shorter than for other forms of radiation therapy. RayStation was selected jointly by Yamagata University Hospital and Toshiba, which is supplying the treatment delivery system. The decision was motivated by RayStation’s outstanding functionality and comprehensive support for this cutting-edge treatment technique. The RayStation installation will include modules for carbon pencil beam scanning with robust biological optimization (using both the MKM and LEM models), deformable registration, dose tracking and adaptive therapy. The facility expects to treat its first patients by early 2020. Toshiba’s treatment delivery system will comprise two treatment rooms, a fixed-port room and a 360-degree rotating compact superconducting gantry. The facility will be the most compact carbon ion installation in the world, and one of the few integrated into a general hospital. Johan Löf, CEO of RaySearch, says: “RaySearch is committed to providing the leading support for cutting-edge techniques such as carbon ion therapy, and we are very pleased to meet the needs of Yamagata University Hospital and Toshiba. RayStation has a strong and growing user base in Japan, and we will continue to focus resources on this technologically advanced market.”   About Yamagata University HospitalYamagata University Hospital is a major general hospital located in Yamagata prefecture, northern Japan. Established in 1976, the hospital offers a wide range of medical specialties, including oncology. The hospital’s clinical cancer center was established in 2007. Yamagata University Hospital works to pursue its philosophy of “deeply humane and reliable medical care.” About RayStationRayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy*. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability. About RaySearchRaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company recently launched the next-generation oncology information system, RayCare*, which comprises a new product area for RaySearch. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since November 2003. To learn more about RaySearch, go to: www.raysearchlabs.com * Subject to regulatory clearance in some markets.  For further information, please contact:Johan Löf, President and CEO, RaySearch Laboratories AB (publ)Telephone: +46 (0)8-510 530 00johan.lof@raysearchlabs.com

ExpreS2ion resolves on a preferential rights issue to accelerate the Company’s development

The proceeds from the preferential rights issue are expected to finance:  · Working capital to, on its own, pursue additional projects regarding vaccines and candidate drugs that the Company regularly encounter on the market.  · Resources to create more value in the joint venture AdaptVac and its development projects.  · Further development of the Company’s platform with new products that will strengthen the Company's position in new market segments and generate new clients, thereby increasing the Company's short-term earnings as well as long-term possibilities.  A comment from CEO Steen Klysner  "Our positive development since the listing in 2016 has increased the Company's revenue significantly, and at the same time we have reached a unique and favourable position in the market. The Company's board and management, together with major shareholders, deem the Company’s limited working capital a limiting factor in developing the Company in an optimal way. We regularly encounter opportunities with potential to create significant value for the Company, that we are forced to decline because of resource shortages. The number of opportunities has increased, both thanks to our joint ownership in the promising company AdaptVac and as a direct consequence of our increased market efforts. Additional capital would increase the pace of our process towards achieving critical mass for our core activities, ensure a strong value development for the Company's existing assets, and at the same time enable us to invest in and develop additional assets. The strong confidence in the Company is seen not in the least through subscription commitments of approximately 57 % from management, major shareholders and institutions.  Purpose of the preferential rights issue ExpreS2ion has increased the number of projects and its revenue during the last 12 months. Additionally, in 2017, the joint venture AdaptVac ApS was formed together with NextGen Vaccines ApS, a spin-out from the University of Copenhagen, which has a synergistic and revolutionary platform technology for vaccines and vaccine-like treatments, and a pipeline of early, promising pharmaceutical projects. To finance this opportunity, ExpreS2ion carried out a preferential rights issue of around MSEK 3.9 in August 2017. In addition to the therapeutic, breast cancer related vaccine previously made public by the Company, the AdaptVac pipeline contains another candidate that, in early studies, has shown promising results compared to existing therapies/vaccines. Due to competitive reasons, the Company cannot announce which indications this candidate is developed for at this time, but the plug-and-play procedure that is integrated in the technology is ideal for quickly developing advanced candidate drugs. With additional resources, the pace for initiating the development of one-two new candidates can be increased. Following the Company's success with the applied development strategy, and the opportunities it has created, the board, management and major shareholders now deem this strategy and business model, primarily based on financing business development by increasing core business revenues, to be insufficient in enabling the Company to pursue encountered opportunities in an optimal way going forward. Currently, the Company is mainly relying on on-going revenue to finance development activities, which results in lost revenues and business opportunities in situations where a larger working capital would enable the Company to benefit from market needs and utilise additional opportunities to create value with significant potential. Additional capital would also increase the pace of the ongoing development of the Company's core activities, thus accelerating the process of achieving critical mass and the financial strength and economies of scale that this would entail. Additionally, an increase of liquid funds would ensure a higher pace in the development of existing pharmaceutical assets in the joint venture AdaptVac, as well as enable the Company to enter into new agreements and initiate projects for highly valued pharmaceutical assets and other similar opportunities.   In view of the above, ExpreS2ion is now planning to carry out a preferential rights issue of approximately MSEK 19.2 to finance a development plan consisting of a number of selected elements that combined will enable consolidation, development and expansion of the Company’s core business into a profitable and revenue generating platform. This will also enable the Company to invest in AdaptVac to increase the value of its technology platform and pharmaceutical projects significantly, and to pursue new opportunities to create value in synergy with the Company’s platform.   Summary of the offer  · Subscription period: February 8 - 27 2018  · Subscription price: SEK 8.00 per share  · Volume of issuance: The offer comprises a maximum of 2,400,403 shares, corresponding to SEK  19,203,224  · Record date and preferential right: Those registered as shareholders in ExpreS2ion Biotech Holding AB on the record date February 2, 2018 have preferential right to subscribe for shares in the planned rights issue. For each held share, one (1) subscription right is received. Four (4) subscription rights entitle to subscription of one (1) new share. Please note that the public is also invited to subscribe for shares in the rights issue  · Number of shares prior to the rights issue: 9,601,612 shares  · Trading period of subscription rights: Trading with subscription rights will be conducted through Nasdaq Stockholm First North from February 8 until February 23, 2018  · Company valuation (pre-money): Approximately MSEK 76.8  · Trading period of BTAs: Trading with BTAs will be conducted through Nasdaq Stockholm First North from February 8, 2018 until the rights issue is registered at the Swedish Company Authority (“Bolagsverket”). The registration is expected to be finished in the middle of March 2018.  · Subscription commitments: ExpreS2ion has received subscription commitments of approximately MSEK 10.9 corresponding to approximately 57 percent of the right issue’s total volume, from persons and entities including the management of the company, major shareholders and institutions  Full terms and instructions, information on subscription commitments and memorandum, teaser and subscription form without preferential right will be published on the company's (www.expres2ionbio.com) and Sedermera Fondkommissions (www.sedermera.se) websites no later than the beginning of the subscription period.  Financial advisor Sedermera Fondkommission is ExpreS2ion’s financial advisor in connection with the preferential rights issue. Certified Adviser  Sedermera Fondkommission is the Certified Adviser of ExpreS2ion Biotech Holding AB.

Non-cash charge from concluded impairment and revaluated U.S. tax assets

· Impairment testing, announced in conjunction with restated numbers according to new segment structure December 8, 2017, is finalized resulting in SEK 14.2 b. write-down · Revaluation of U.S. deferred tax assets due to change in U.S. corporate income tax rate, resulting in a non-cash tax charge of SEK 1.0 b. · No impact on cash flow, but impairments will have negative impact on reported Operating Income mainly in segments Digital Services and Other, while tax asset revaluation will impact income tax expenses, in Q4 2017 · All numbers are unaudited, final numbers will be published in the Q4 2017 report Ericsson’s (NASDAQ: ERIC) impairment testing that was announced in conjunction with the restated financials according to new segment structure on December 8, 2017, is completed. This followed the focused business strategy announced in March 2017 and further detailed at the Capital Markets Day, November 8, 2017. The result of the impairment testing is a write-down of SEK 14.2 b. distributed as follows: Segment Digital Services: impairment of SEK 6.7 b. of goodwill and SEK 0.4 b. of intangible assets Segment Other: impairment of SEK 6.0 b. of goodwill, SEK 0.3 b. of intangible assets, and SEK 0.4 b. of fixed assets Segment Managed Services: impairment of SEK 0.3 b. of deferred costs related to termination of certain transformation activities Segment Networks: impairment of SEK 0.2 b. of capitalized development expenses related to technologies that are no longer planned to be used The majority of goodwill originates from investments made 10 years ago or more, and has limited relevance for Ericsson’s business going forward. All impairments are non-cash accounting adjustments. The adjustments have no influence on Ericsson’s commitment to executing its strategies and to investing in technology to support customers’ success. U.S. tax asset revaluation The lowering of the U.S. corporate income tax rate from 35% to 21% (effective 1 January 2018) requires a revaluation of U.S. deferred tax assets. The current estimated impact will be a non-cash charge to the Group income statement of approximately SEK 1.0 b. that will impact income tax expenses. The impairments and the tax asset revaluation will impact reported net income in Q4 2017, but have no impact on Ericsson’s cash flow and cash position in Q4 2017. Ericsson’s gross and net cash position remain strong. An impairment is not an indication of the performance of the business in the quarter. Ericsson’s fourth quarter and full year 2017 earnings report is scheduled for January 31, 2018. FOR FURTHER INFORMATION, PLEASE CONTACT Contacts investors and financial analysts: Peter Nyquist, Head of Investor RelationsPhone: +46 10 714 64 99E-mail:  peter.nyquist@ericsson.com Åsa Konnbjer, Director, Investor RelationsPhone: +46 10 713 39 28 E-mail:  asa.konnbjer@ericsson.com Stefan Jelvin, Director, Investor RelationsPhone: +46 10 714 20 39E-mail:  stefan.jelvin@ericsson.com Rikard Tunedal, Director, Investor RelationsPhone: +46 10 714 54 00E-mail:  rikard.tunedal@ericsson.com Contacts media enquiries: Peter Olofsson, Head of Corporate CommunicationsPhone: +46 10 719 18 80E-mail:  media.relations@ericsson.com Corporate CommunicationsPhone: +46 10 719 69 92E-mail:  media.relations@ericsson.com NOTES TO EDITORS For media kits, backgrounders and high-resolution photos, please visit www.ericsson.com/press FOLLOW US: www.twitter.com/ericssonwww.facebook.com/ericssonwww.linkedin.com/company/ericssonwww.youtube.com/ericsson  MORE INFORMATION AT: News Center media.relations@ericsson.com (+46 10 719 69 92)investor.relations@ericsson.com (+46 10 719 00 00) Ericsson is a world leader in communications technology and services with headquarters in Stockholm, Sweden. Our organization consists of more than 111,000 experts who provide customers in 180 countries with innovative solutions and services. Together we are building a more connected future where anyone and any industry is empowered to reach their full potential. Net sales in 2016 were SEK 222.6 billion (USD 24.5 billion). The Ericsson stock is listed on Nasdaq Stockholm and on NASDAQ in New York. Read more on www.ericsson.com.

Play’n GO’s games now certified in Spain and Colombia

16th January 2018 – Omni-channel slots specialist Play’n GO has been licensed and certified as compliant to supply its games to two more major markets, Spain and Colombia. Rigorous certification processes recently confirmed that the two jurisdictions will allow Play’n GO titles to be used by locally licensed operators. The Spanish igaming sector has confirmed its position as one of Europe’s largest markets of late, while the Colombian industry looks to continue its impressive growth of the last year, and Play’n GO will look to exploit these opportunities with a concerted sales push in the coming months. The supplier is already compatible with numerous jurisdictions, including Alderney, Denmark, Italy, the United Kingdom, Malta, Belgium, Croatia, Czechia, Lithuania, Latvia and Romania, with other territories currently in the process of confirming Play’n GO’s games. Sissel Weitzhandler, Group Compliance Manager of Play’n GO, said: “Play’n GO has a strong history of providing quality, certified gaming content to European and LatAm operators, and it’s these licences which make us attractive to local operators. “These in-depth certification processes differ from country to country, so it’s testament to our compliance team that we’ve acquired these without any issues, particularly with Spain and Colombia’s regulatory environments being so different. “Each certification program or software licence we acquire secures our position as the leading games provider to regulated markets, and the experience gained throughout the numerous processes will benefit us as we continue to grow into new territories.” Play’n GO will showcase its new product verticals on stand N3-460 at ICE 2018, with delegates able to see how its expanded expertise and gaming provision can benefit both online and land-based casino operations. ENDS

Consumers’ 5G wish list outlines action plan for operators

What will it take for operators to gain consumers’ trust as they gear up for a 5G future? Ericsson (NASDAQ: ERIC) today presented Towards a 5G consumer future – its Consumer and Industry Insight report that discusses the six calls to action from consumers that operators need to act upon to provide a foundation for adoption of 5G technology. The report , the biggest 5G consumer expectation study to date, represents the views of 800 million smartphone users worldwide. Jasmeet Sethi, Senior Advisor, Ericsson Consumer & Industry Lab, says: “Our latest study does not look at a consumer view on 5G in isolation, but rather uncovers unmet consumer needs that must be fulfilled by operators on the way to 5G. From offering an effortless buying experience to focusing on real network performance, consumers are demanding changes they would like to see already made today.” Here are the six consumer calls to action: Provide us with effortless buying experience Consumers perceive the telecom market to be too complex. With six in 10 smartphone users grappling with the complexity of mobile data plans, there is considerable misalignment between what users buy and what they use. With only three in 10 smartphone users satisfied with the way their operator presents plans online, the digital telecom experience is neither simple nor effortless. Offer us a sense of the unlimited Consumers aren’t counting on unlimited data plans, but they are looking for a sense of the unlimited. Peace of mind rather than actual use is the main motivator behind buying unlimited data plans and operators are urged to explore alternative ways to offer this feeling of freedom. Treat gigabytes as currency The average smartphone user has 31 gigabytes of unused mobile data left over per year, enough to make 65 hours of video calls, spend 517 hours streaming music, or binge-watch six seasons of a TV show like Game of Thrones, equating to as much as 1.5 terabytes over their lifetime. Two in five consumers would like to use this excess as currency and expect to be able to save, trade or gift unused data. Offer us more than just data buckets Faster broadband speeds and fair wireless contracts are considered more important than the data buckets that currently dominate the market. As bundled video content and innovative data plans play an increasingly important role in the choice of operator and service bundle, consumers want operators to innovate, evolve and personalize data plans. Give us more with 5G Contrary to the belief that consumers are uninterested in 5G, globally the idea of 5G services appeals to 76 percent of smartphone users; 44 percent are in fact willing to pay for 5G. Consumers expect most 5G services to go mainstream within 3 to 4 years of the launch and over 50 percent expect to be using 5G-enriched services within two years of the launch. Over a third expect 5G to offer capabilities beyond speed, network coverage and lower prices: improvements such as better battery life and the ability to connect not only devices but also the Internet of Things. Consumers also predict an end to paying for gigabytes consumed and instead expect to pay a single fee for each 5G service or connected device. Keep networks real for us Moving towards a 5G future, consumers are calling on operators to avoid baseless marketing slogans and instead focus on real network experience, increasing the honesty of their marketing. The report shows that only four percent trust operators’ own advertising and network performance statistics. The insights in the report are based on Ericsson ConsumerLab’s global research activities  of more than 20 years, and draw on data from a survey of 14,000 iPhone and Android smartphone users aged between 15 and 65. The views expressed in the survey are representative of 800 million consumers across Argentina, Brazil, China, Egypt, Finland, France, Germany, Indonesia, Ireland, Japan, Mexico, South Korea, the UK and the US. For more detailed information, please download the full report here .   NOTES TO EDITORS For media kits, backgrounders, and high-resolution photos, please visit www.ericsson.com/press FOLLOW US: www.twitter.com/ericssonwww.facebook.com/ericssonwww.linkedin.com/company/ericssonwww.youtube.com/ericsson  MORE INFORMATION AT: News Center  media.relations@ericsson.com(+46 10 719 69 92) investor.relations@ericsson.com(+46 10 719 00 00) Ericsson is a world leader in communications technology and services with headquarters in Stockholm, Sweden. Our organization consists of more than 111,000 experts who provide customers in 180 countries with innovative solutions and services. Together we are building a more connected future where anyone and any industry is empowered to reach their full potential. Net sales in 2016 were SEK 222.6 billion (USD 24.5 billion). The Ericsson stock is listed on Nasdaq Stockholm and on NASDAQ in New York. Read more on www.ericsson.com.

Axel Johnson International expands fluid handling service capacity in France

AxFlow France, part of the Fluid Handling Solutions business group of Axel Johnson International, has taken a strategic step to strengthen its service capacity in the French fluid handling market with the acquisition of RDC Production. The acquisition is in line with AxFlow’s strategy of growing by adding value-added service as a differentiator from its competition. The transaction closed January 12. RDC specialises in industrial equipment service and maintenance for pumps, heat exchangers, homogenizers, and valves. It also conducts integrity tests on exchangers and tanks and offers multi-brand equipment, spare parts and tailor-made systems. Based in the west of Paris, RDC operates in well equipped, modern facilities with 43 employees which include many highly skilled technicians with the expertise to take on a broad range of service applications. “RDC is a solid, well-respected provider of fluid handling service for the food, pharma, chemicals, petrochemicals and cosmetics – all important business segments for AxFlow,” says Ole Weiner, CEO of AxFlow Holding. “Adding RDC’s expertise in service will reinforce our solution-provider strategy and allow us to improve the service offer in the French market.” Meanwhile, RDC is expected to benefit from the increased visibility and sales activity generated through AxFlow sales staff as well as through knowledge-sharing between the companies. “Joining an internationally renowned group like AxFlow is a real opportunity for RDC Productions to develop! We are honoured to now be a part of it," says Raymond Chevallier, "This will offer great opportunities to our staff, and our future together will ensure sustainable and profitable growth. RDC and AxFlow are two complementary companies, and the synergy of their know-how will be the key to success.”   For further information, please contact: Hans Glemstedt, Head of Strategy and M&A, Axel Johnson International, +46 (0)8 453 77 41, hans.glemstedt@axinter.com Ole Weiner, CEO of AxFlow Holding, +46 (0)8 545 476 72, ole.weiner@axflow.com Lars Carlson, CFO of AxFlow Holding, +46 (0)702 74 05 35, lars.carlson@axflow.com   AxFlow France has been active in the French market for nearly 30 years. It is part of the AxFlow Group, the Fluid Handling Solutions business group within Axel Johnson International. The AxFlow Group is active in 27 countries and has approximately 600 employees and an annual turnover of EUR 180 million.  

Vontobel issues first bitcoin open end tracker on NGM Sweden

The Vontobel certificate on Bitcoin in SEK is an open end tracker certificate that offers investors a simple tradable market access to invest in bitcoin. Having issued the first bitcoin tracker certificate in Switzerland and Germany as well as Mini Futures Short in Switzerland, which enable investors to trade on a falling Bitcoin price, the listing of the Bitcoin tracker certificate at NGM marks a Vontobel premiere in Sweden, since local investors will now be able to trade Vontobel high market making quality in the dedicated retail investor segment of NGM.. The tracker certificate is an attractive alternative to the direct investment in the cryptocurrency and provides various advantages: the tracker certificate is tradable like a stock on NGM, i.e. trading hours, market making quality as well as liquidity and settlement quality from a proven regulated exchange will be claimed. Investors do not have to get access to unregulated Bitcoin exchanges and intransparent settlement processes as well as to take care of digital storage on their private wallets. All this is provided by Vontobel as the issuer of the certificate. However, investors have to take into account the issuer risk of Vontobel as well as the market risk of Bitcoin as the respective underlying. The certificate has an open end structure and a yearly management fee of 1,5% p.a. A listing application has been submitted for admission to NGM. The first day of trading will be 16 January 2018. Starting on the launch day, investors will be able to trade the Vontobel open end tracker certificate on the secondary market, i.e. buying or selling at the applicable bid/offer prices. “The new bitcoin certificate will give investors a simple and transparent instrument of investing in Bitcoin on NGM. Vontobel is thus once again demonstrating its capacity for innovation as one of Sweden’s leading providers of structured products,” said Heiko Geiger, Head of Public Distribution Europe at Vontobel Investment Banking. “It is our pleasure to announce that Vontobel is the first issuer to offer an open end tracker certificate on bitcoin cryptocurrency. This will further strengthen our position on the Nordic derivatives market” says Tommy Fransson, deputy CEO of NGM. Vontobel was the first to launch an investment product on bitcoin in Switzerland in July 2016 and in Germany in November 2016. The trackers on bitcoin launched in Switzerland proved to be a large success. In 2017, both Bitcoin tracker certificates aggregated to a total volume of more than 500 Mio CHF on the Swiss Exchange SWX and range together on No. 2 based on turnover. Concerning transactions, both tracker certificates generated by far the most transactions and ranged as No. 1 and No. 2 in the statistics. Bitcoin was the second most traded instrument by turnover as well as by transactions in Germany. Vontobel Investment Banking Vontobel Investment Banking creates specialized investment solutions for private and institutional clients. We follow a customer-centered digital business model, manage risks carefully, and build compelling service packages to get our clients ahead. We emphasize on truly understanding our clients’ needs. We use our expertise to anticipate trend reversals, risks as well as opportunities, in order to successfully exploit them for you. We only do, what we master and develop solutions we believe in. We take clear decisions and act with determination. We are proud of our specialized offering, which includes structured products, transaction banking, corporate finance, brokerage, as well as solutions for External Investment Advisors, and digital platforms. For our competence in Research, we regularly get awarded. This is how we create added value for you. Legal information This document is for information purposes only and does notconstitute an offer of any kind. The services described in the document aresupplied under the agreement signed with the service recipient. The nature,scope and prices of services and products may vary from one country to anotherand may change without notice at any time. Certain services and products arenot available worldwide or from all companies of Vontobel. In addition, theymay be subject to legal restrictions in certain countries. VontobelGotthardstrasse 43, 8022 ZürichSwitzerlandT +41 58 283 7111vontobel.com

Management changes in Cloetta

Katarina Tell succeeds Lars Påhlson who last year announced that he intends to retire during 2018. Katarina Tell will report to Henri de Sauvage-Nolting, CEO, and be part of Group Management. She will assume her position at the latest 1 August, 2018. Katarina Tell is currently General Manager Findus Sweden. She has previously been working at both Kraft Heinz and Findus where she, among others, held positions as General Manager Kraft Heinz Northern and Eastern Europe, Retail Sales Manager Kraft Heinz Sweden and Business Development Manager Findus. Katarina Tell was born in 1970 and holds a BS in Marketing and Administration from Lund University and a Master’s degree in Food Nutrition from Umeå University. “Katarina Tell has a solid and proven track record from the fast moving consumer goods industry. She is a proven leader and knows the Swedish retail market very well. Sweden is Cloetta’s largest market and is after the acquisition of Candyking of even greater importance”, says Henri de Sauvage-Nolting, President and CEO of Cloetta. Michiel Havermans will be responsible for all of Cloetta’s export business including the business in the UK. Michiel Havermans will report to Henri de Sauvage-Nolting, CEO, and be part of Group Management. He will assume his position 1 March, 2018. Michiel Havermans has been working at Perfetti van Melle in various positions for more than 15 years, including Export Director, Country Manager UK and Managing director Vietnam and the Philippines. He is currently working at United Dutch Breweries (UDB) as Regional Director sales and marketing for Europe, Middle East and Americas. Michiel Havermans was born in 1973 and has a MSc in Economics from Erasmus University in Rotterdam. “Michiel Havermans has a solid and proven track record from leading and developing international export business in the confectionery industry, including leading a business in the UK. To grow international markets with a special emphasis on The Jelly Ben Factory is an important part of Cloetta’s growth strategy”, says Henri de Sauvage-Nolting.

The FCCA will approve the merger of Lemminkäinen and YIT unconditionally and it will likely be completed on 1 February 2018

LEMMINKÄINEN CORPORATION  STOCK EXCHANGE RELEASE 16 JANUARY 2018 AT 2:00 P.M. This stock exchange release may not be published or distributed, in whole or in part, directly or indirectly, in or into Canada, Australia, Hong Kong, South Africa, Japan or any other country where such publication or distribution would violate applicable laws or rules or would require additional documents to be completed or registered or require any measure to be undertaken, in addition to the requirements under Finnish law. For further information see "Important notice" below. THE FCCA WILL APPROVE THE MERGER OF LEMMINKÄINEN AND YIT UNCONDITIONALLY AND IT WILL LIKELY BE COMPLETED ON 1 FEBRUARY 2018 The Boards of Directors of Lemminkäinen Corporation (“Lemminkäinen”) and YIT Corporation ("YIT") have on 19 June 2017 agreed on combining the companies through a statutory absorption merger under the Finnish Companies Act. Pursuant to the merger plan, Lemminkäinen shall be merged into YIT so that all assets and liabilities of Lemminkäinen shall be transferred without a liquidation procedure to YIT, and Lemminkäinen will be dissolved. The Extraordinary General Meetings of Lemminkäinen and YIT have on 12 September 2017 approved the merger. The completion of the merger is still subject to, inter alia, merger control approval from the Finnish Competition and Consumer Authority (the “FCCA”). The Finnish Market Court has granted the FCCA an extension for investigating the merger until 26 January 2018.    The FCCA has announced today, 16 January 2018, that it will approve the merger as such. The FCCA will issue its final approval decision on its due date, 26 January 2018, whereupon Lemminkäinen will separately make a disclosure on the decision.  Once the FCCA has given its final approval decision, Lemminkäinen and YIT have received all required authority approvals for completing the merger. Lemminkäinen and YIT intend to complete the merger on 1 February 2018 provided that all the conditions required for the completion of the merger are fulfilled at said time.   LEMMINKÄINEN CORPORATIONCorporate Communications  ADDITIONAL INFORMATION:Johan Nybergh, General CounselTel. +358 2071 53378johan.nybergh@lemminkainen.com DISTRIBUTION:Nasdaq Helsinki LtdKey mediawww.lemminkainen.com  Lemminkäinen is an expert in complex infrastructure construction and building construction in Northern Europe and one of the largest paving companies in its market. Together with our customers and 4,700 professionals we employ, we build a sustainable society. In 2016, our net sales were EUR 1.7 billion. Lemminkäinen Corporation’s share is quoted on Nasdaq Helsinki Ltd. www.lemminkainen.com  IMPORTANT NOTICE The distribution of this release may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restrictions. The information contained herein is not for publication or distribution, directly or indirectly, in or into Canada, Australia, Hong Kong, South Africa or Japan. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This release is not directed to, and is not intended for distribution to or use by, any person or entity that is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction. No part of this release, nor the fact of its distribution, should form the basis of, or be relied on in connection with, any contract or commitment or investment decision whatsoever. The information contained in this release has not been independently verified. No representation, warranty or undertaking, expressed or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or the opinions contained herein. Neither Lemminkäinen nor YIT, nor any of their respective affiliates, advisors or representatives or any other person, shall have any liability whatsoever (in negligence or otherwise) for any loss however arising from any use of this release or its contents or otherwise arising in connection with this release. Each person must rely on their own examination and analysis of Lemminkäinen, YIT, their respective subsidiaries, their respective securities and the merger, including the merits and risks involved. Notice to Lemminkäinen Shareholders in the United States The YIT shares to be issued in connection with the merger have not been registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and are being issued in reliance on the exemption from registration set forth in Rule 802 under the Securities Act.   YIT and Lemminkäinen are Finnish companies and the issuance of YIT shares will be subject to procedural and disclosure requirements in Finland that may be different from those of the United States. Any financial statements or other financial information included in this release may have been prepared in accordance with non-U.S. accounting standards that may not be comparable to the financial statements of U.S. companies or companies whose financial statements are prepared in accordance with generally accepted accounting principles in the United States. It may be difficult for U.S. shareholders of Lemminkäinen to enforce their rights and any claims they may have arising under U.S. federal securities laws in connection with the merger, since YIT and Lemminkäinen are located in non-U.S. jurisdictions, and some or all of YIT's and Lemminkäinen's officers and directors may be residents of countries other than the United States. As a result, U.S. shareholders of Lemminkäinen may not be able to sue YIT or Lemminkäinen or their respective officers and directors in a court in Finland for violations of U.S. federal securities laws. Further, it may be difficult to compel YIT or Lemminkäinen to subject themselves to the jurisdiction or judgment of a U.S. court. Lemminkäinen’s shareholders should be aware that YIT may purchase Lemminkäinen’s shares otherwise than under the merger, such as in open market or privately negotiated purchases, at any time during the pendency of the proposed merger. Notice to Shareholders in the United Kingdom This release, the merger prospectus and the English language offering circular are for distribution only to persons who (i) have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the "Financial Promotion Order"), (ii) are persons falling within Article 43 of the Financial Promotion Order (for example as shareholders in Lemminkäinen entitled to receive the merger consideration shares pursuant to the Finnish Companies Act (21.7.2006/624, as amended)), (iii) are persons falling within Article 49(2)(a) to (d) ("high net worth companies, unincorporated associations etc.") of the Financial Promotion Order, (iv) are outside the United Kingdom, or (v) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of the merger consideration shares may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "relevant persons"). The release, the merger prospectus and the English language offering circular are directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which these documents relate, are available only to relevant persons and will be engaged in only with relevant persons. Notice to Shareholders in the European Economic Area The English language offering circular has been prepared on the basis that any offer of the merger consideration shares in any Member State of the European Economic Area ("EEA") other than offers (the "Permitted Public Offers") which are made prior to the Effective Date (as defined in the English language offering circular), and which are contemplated in the English language offering circular in Finland once the Finnish language merger prospectus has been approved by the competent authority in Finland and published in accordance with the Prospectus Directive, and in respect of which YIT has consented in writing to the use of the English language offering circular, will be made pursuant to an exemption under the Prospectus Directive from the requirement to publish a prospectus for offers of the merger consideration shares. Accordingly any person making or intending to make an offer in that Member State of the merger consideration shares which are the subject of the offer contemplated in the English language offering circular, other than the Permitted Public Offers, may only do so in circumstances in which no obligation arises for YIT to publish a prospectus pursuant to Article 3 of the Prospectus Directive or supplement a prospectus pursuant to Article 16 of the Prospectus Directive, in each case, in relation to such offer. YIT has not authorised, nor does it authorise, the making of any offer (other than Permitted Public Offers) of the merger consideration shares in circumstances in which an obligation arises for YIT to publish or supplement a prospectus for such offer. In relation to each Member State of the EEA, with effect from and including the date on which the Prospectus Directive was implemented in that Member State (the "Relevant Implementation Date") no offer has been made and will not be made (other than a Permitted Public Offer) of the merger consideration shares which are the subject of the offering contemplated by the English language offering circular to the public in that Member State, except that, with effect from and including the Relevant Implementation Date, an offer of such merger consideration shares is made to the public in that Member State: a)     to any legal entity which is a qualified investor as defined in the Prospectus Directive; b)     to fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted under the Prospectus Directive, subject to obtaining the prior consent of YIT for any such offer; or c)     in any other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no offer of the merger consideration shares is made which would require YIT to publish a prospectus pursuant to Article 3 of the Prospectus Directive or supplement a prospectus pursuant to Article 16 of the Prospectus Directive. The expression an offer of the merger consideration shares to the public in relation to any merger consideration shares in any Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the merger consideration shares to be offered so as to enable an investor to decide to purchase or subscribe to the merger consideration shares, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State. The expression "Prospectus Directive" means Directive 2003/71/EC (as amended), and includes any relevant implementing measure in the EEA Member State concerned.

GomSpace signs contract for low-inclination launch on Virgin Orbit’s LauncherOne

GomSpace has purchased a launch for several nanosatellites onboard a LauncherOne rocket from the California based company Virgin Orbit. The flight, which is bound for a low-inclination orbit, is scheduled to occur in early 2019. GomSpace will use the launch to further build out a constellation of small satellites that will use Automatic Dependent Surveillance-Broadcast (ADS-B) and Automatic Identification System (AIS)  signal monitoring to track civilian aircraft and ocean-going vessels. This satellite constellation will provide continuous monitoring between 37 degrees North and 37 degrees South, helping provide global situational awareness for air-traffic controllers and shipping companies, and aiding in the identification and location of wayward or missing planes and ships. The satellites slated for flight on LauncherOne are based closely on the flight-proven hardware used in the successful GOMX-1 and GOMX-3 missions, and will be designed, manufactured, and commissioned by GomSpace. The constellation will be operated by GomSpace’s Mauritius-based customer, Aerial & Maritime Ltd., once in orbit.  “GomSpace is always happy to take another step forward as a global leader in the nanosatellite community. Virgin Orbit and LauncherOne are a key part of building out our ADS-B and AIS monitoring constellation, which is going to fill a need that is both socially and commercially important,” said GomSpace CEO Niels Buus. “Seeing the great work happening here at Virgin Orbit’s rocket factory today, we are more excited than ever for our flight on LauncherOne.” Virgin Orbit CEO Dan Hart added: “GomSpace has already proven that they have an excellent technological solution that works in space. Now, they need to build out the full constellation, and I’m thrilled that our team at Virgin Orbit is playing a key role in that. The ADS-B and AIS tracking that this constellation will provide helps make us here on Earth safer and more efficient, and we think that is an incredibly important mission.” Virgin Orbit is currently in the process of qualification and test flight for the LauncherOne service, which includes both a two-stage expendable rocket and a fully-reusable air-launch platform. The company has a fully-assembled pathfinder rocket on the test stand in Mojave, CA, and several more in manufacturing and assembly in Long Beach, CA. The system’s 747-400 flying launch pad has begun its flight test campaign. LauncherOne is designed to provide highly responsive, reliable, and affordable flights to Low Earth Orbit to small satellites. The initial flight of the LauncherOne system is targeted for the first half of 2018.  MEDIA INQUIRES:  Virgin Orbit: William Pomerantz, william.pomerantz@virginorbit.com  GomSpace: Niels Buus, nbu @ gomspace.com (tfi@gomspace.com) ABOUT VIRGIN ORBIT  Virgin Orbit provides dedicated, responsive, and affordable launch services for small satellites. Virgin Orbit is developing LauncherOne, a flexible launch service for commercial and government-built satellites. LauncherOne rockets are designed and manufactured in Long Beach, California, and will be air-launched from a dedicated 747-400 carrier aircraft capable of operating from many locations in order to best serve each customer’s needs. Virgin Orbit’s systems are currently in an advanced stage of testing, with initial orbital launches expected soon. To learn more or to apply to join Virgin Orbit’s talented and growing team, visit virginorbit.com.  ABOUT GOMSPACE  GomSpace is a globally leading designer, integrator, and manufacturer of high-end nanosatellites for customers in the academic, government, and commercial markets. Our positions of strength include systems integration, nanosatellite subsystems, and advanced miniaturized radio technology. Our international team is devoted to understanding our customers’ requirements and delivering flawlessly. We are listed in the Nasdaq First North Premier exchange in Stockholm (GOMX), headquartered in Denmark and have subsidiaries in Sweden, North America, and Singapore. We are currently more than 150 employees and we service customers in more than 50 countries. For more information, please visit our website at gomspace.com.   ABOUT AERIAL & MARITIME LTD.  Aerial & Maritime, Ltd. (“A&M”) is a global data provider and the company’s satellites will be capable of monitoring civilian aircraft and vessels based on reception of ADS-B and AIS-signals, respectively. A&M is an affiliated company of GomSpace Group AB. 

Closing of Biotage’s acquisition of Horizon Technology

Stockholm – Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) today announces the closing of the acquisition of all outstanding shares in the privately held company Horizon Technology, Inc. (Horizon) based in New Hampshire, US, in accordance with contract and public announcement of December 6th, 2017. The purchase price adjusted for actual net cash at the closing date is approx. USD 17.9 million, corresponding to approx. SEK 143.4 million[1], based on an enterprise value of approx. USD 16.4 million and cash of approx. USD 1.5 million.This information was submitted for publication, through the agency of the contact persons set out above, at 17.00 CET on January 16, 2018.[1] Based on an exchange rate USD/SEK of 0.1247. This exchange rate has been used throughout this press release for the conversion of USD/SEK.Contact persons:Torben Jörgensen, CEOTel: +46 707 49 05 84, torben.jorgensen@biotage.com                   Erika Söderberg Johnson, CFOTel: +46 707 20 48 20, erika.johnson@biotage.com  About BiotageBiotage offers efficient separation technologies from analysis to industrial-scale and high-quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by public authorities, academic institutions, contract research and contract manufacturing organizations and in the pharmaceutical and food industries, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan, South Korea and India. Biotage has approx. 340 employees and had sales of 667 MSEK in 2016. Biotage is listed on Nasdaq Stockholm. Website: www.biotage.com 

Ericsson 5G Radio Dot gives big boost to indoor coverage

With mobile data traffic surging by eight times and 1 billion 5G subscriptions expected by the end of 2023, mobile operators must meet consumer and enterprise demand for applications such as 4K/8K video streaming, virtual reality/augmented reality, and immersive media. This puts out a strong call for indoor coverage, which cannot be easily addressed by outdoor radio deployments as modern building materials can block outdoor radio signals. Ericsson (NASDAQ: ERIC) is meeting this challenge by introducing the 5G Radio Dot, a small cell radio designed to satisfy the advanced indoor mobile broadband performance requirements demanded by 5G. Building on the elegant design of previous generations, the 5G Radio Dot takes less than half the time to install compared to other indoor solutions, and will support the new 5G mid-bands (3-6GHz) with speeds up to 2Gbps. Nishant Batra, Head of Product Area Network Infrastructure at Ericsson, says: “Adding small cell solutions to our 5G portfolio is a natural part of the network evolution. Enterprises have been asking for first-rate connectivity indoors, as well as higher speeds and capacity to serve advanced use cases that cannot be addressed by traditional indoor systems. Our 5G portfolio, bolstered by small cells, will enable operators to meet these demands.” Daryl Schoolar, Practice Leader, Ovum, says: “Now that first 5G standards are here, vendors are going to need multiple radio solutions to help operators roll out their new 5G networks. Ericsson takes an important initial step in this direction by adding indoor small cell 5G solutions to its already existing outdoor 5G RAN portfolio. This new indoor solution from Ericsson is going to be attractive for operators wanting to offer enterprises good indoor performance for enhanced mobile broadband and new industrial applications that can’t be met by Wi-Fi or 5G base stations deployed outdoors.” Huang Yuhong, Deputy Head of China Mobile Research Institute, says: “The Ericsson Radio Dot System is already widely deployed in our 4G networks. As an innovative small cell solution, it further enhances our indoor solutions and will continue to play a key role in the 5G era. We’re happy to see Ericsson evolving the Radio Dot to 5G technology.” As a natural evolution of the Ericsson Radio Dot System , operators will be able to deploy 5G Radio Dot next to 4G solutions using the same cabling infrastructure, same network architecture and dot locations. This innovative small cell solution provides a simple upgrade path for existing Radio Dot System deployments, adding 5G technology capabilities. It is easy to add frequency, capacity, and technologies. Feng Yi, Director of Wireless Technology Department, China Unicom Network Technology Research Institute, says: “Our users enjoy excellent indoor coverage in thousands of buildings in China, including shopping malls, thanks to Ericsson Radio Dot solution. As a scalable system, it enables us to meet the growing demand for seamless indoor connectivity. It is great to see Ericsson evolve the solution to 5G as we prepare for the next-generation mobile technology.” The Radio Dot System has been successfully deployed for many indoor applications used in large areas such as office buildings, shopping malls, hospitals, and airports. Over time, the small cell solution will also support 5G industrial applications from connected factories to more extreme cases such as connected mining. Ericsson is a pioneer on this front. Its collaboration with Boliden  shows how Radio Dot technology can improve safety and efficiency through the remote control of machines that keep people out of the most dangerous areas of the mine at the most dangerous times. The 5G Radio Dot will undergo trials in late 2018 and will be commercially available in 2019. NOTES TO EDITORS For media kits, backgrounders, and high-resolution photos, please visit www.ericsson.com/press According to Ericsson ConsumerLab reports, 60 percent  of mobile subscribers are unhappy with their indoor cellular connectivity. In January 2018 report, smartphone users rate better indoor and outdoor coverage among the top expectations from 5G . Read more on the 5G Radio Dot  Small Cell Evolution  5G - media kit  FOLLOW US: www.twitter.com/ericssonwww.facebook.com/ericssonwww.linkedin.com/company/ericssonwww.youtube.com/ericsson  MORE INFORMATION AT: News Center  media.relations@ericsson.com(+46 10 719 69 92) investor.relations@ericsson.com(+46 10 719 00 00) Ericsson is a world leader in communications technology and services with headquarters in Stockholm, Sweden. Our organization consists of more than 111,000 experts who provide customers in 180 countries with innovative solutions and services. Together we are building a more connected future where anyone and any industry is empowered to reach their full potential. Net sales in 2016 were SEK 222.6 billion (USD 24.5 billion). The Ericsson stock is listed on Nasdaq Stockholm and on NASDAQ in New York. Read more on www.ericsson.com.

Minesto takes steps towards world’s first ocean current electricity generation

Minesto has recruited a Taiwanese site developer as project manager to the newly established subsidiary Minesto Taiwan Ltd. The local presence allows Minesto to pursue activities within the Asian market with higher intensity than before, says Dr Martin Edlund, CEO of Minesto: “We strengthen the business development organisation and intensify our operations in Taiwan. The installation project to demonstrate the Deep Green technology in tidal streams at Keelung Island is already running and we aim to complete this in 2018. We have also identified and analysed a site in the Kuroshio current. A natural next step is to install our devices there, which could see the world's first electricity generated from ocean currents.” According to Minesto's assessment, Deep Green is the only verified technology to cost effectively generate electricity from ocean currents, which often are characterised by low-flow stream velocities. By unlocking this untapped natural resource, Minesto's technology can provide communities and businesses around the world with renewable base load power – predictable, continuous production of green electricity at a competitive cost. Consolidates Asian rollout The establishment in Taiwan also consolidates a commercial expansion rollout throughout Asia, by both small-scale autonomously operated Deep Green systems and utility-scale arrays in ocean currents. "We intend to expand the Deep Green product range with a smaller scale system, giving us an additional commercial product to cost-effectively open new markets and business opportunities, not least those in Asia. In Southeast Asia alone, 65 million people live without electricity and many millions more live with unreliable supply, making them dependent on expensive diesel-generated electricity. Marine energy has the potential to meet a substantial share of the need for reliable and clean electricity supply in this part of the world”, says Martin Edlund. For additional information please contact: Magnus MatssonCommunications Manager, Minesto AB+46 70 570 75 08press@minesto.com About Minesto Minesto is a marine energy technology company with the mission to minimise the global carbon footprint of the energy industry by enabling commercial power production from the ocean. Minesto’s award winning and patented product, Deep Green, is the only verified marine power plant that operates cost efficiently in areas with low-flow tidal streams and ocean currents. In May 2015, Minesto secured a €13m investment from the European Regional Development Fund through the Welsh European Funding Office, for the commercial rollout of Deep Green. Minesto was founded in 2007 and has offices in Gothenburg, Sweden, Holyhead, Wales and Portaferry, Northern Ireland. The major shareholders in Minesto are BGA Invest and Midroc New Technology. The Minesto share (MINEST) is traded on the Nasdaq First North Stockholm stock exchange, with G&W Fondkommission as Certified Adviser. Read more about Minesto at www.minesto.com Press images and other media material is available for download via bit.ly/minestomedia. The information in this press release is such that Minesto AB (publ) shall announce publicly according to the EU Regulation No 596/2014 on market abuse (MAR). The information was submitted for publication, through the agency of the contact person set out above, at 07:30 CET on 17 January 2018.

Hans Stråberg proposed as new Chairman of the Board of AB SKF. Colleen Repplier proposed as new Board Member

Gothenburg, 17 January 2018: SKF’s Nomination Committee proposes Hans Stråberg as new Chairman of the Board of AB SKF. Hans Stråberg is Chairman of the Board of Atlas Copco AB, Roxtec AB, CTEK AB, Nikkarit Holding AB; Vice Chairman of the Board of Stora Enso Oyj, Orchid Ortopedics, Inc and Board member of Investor AB, N Holding AB, Mellby Gård AB and Hedson Technologies AB. SKF’s current Chairman of the Board Leif Östling has announced that he will not make himself available for re-election at the Annual General Meeting 2018. The Nomination Committee also proposes Colleen Repplier as new Board member of SKF. Colleen Repplier is currently vice president and general manager at Johnson Controls. She is also a Board member of Kimball Electronics. Baba Kalyani and Marie Bredberg have informed the Nomination Committee that they are not available for re-election. The Nomination Committee proposes that the Board of Directors shall consist of nine members and no deputy members. In addition to the proposed new election of Hans Stråberg and Colleen Repplier, the Nomination Committee proposes the re-election of the Board members Peter Grafoner, Lars Wedenborn, Hock Goh, Alrik Danielson, Nancy Gougarty, Ronnie Leten and Barb Samardzich. The Nomination Committee’s additional proposals will be published in conjunction with the notice of the Annual General Meeting 2018. The Nomination Committee appointed in preparation of the Annual General Meeting 2018 consists of Marcus Wallenberg, FAM, Ramsay Brufer, Alecta, Anders Jonsson, Skandia and Johan Strandberg, SEB Investment Management, besides the Chairman of the Board Leif Östling. Aktiebolaget SKF      (publ)

Skanska presents preliminary year-end results after taking charges related to restructuring and propose maintained dividend

In order to improve profitability Skanska will reduce the size of unprofitable business units and increase focus on cost control and risk management. Skanska will also make a number of organizational and leadership changes. Due to the unsatisfactory performance of several construction units Skanska will take the following actions: restructure the construction operations in Poland, leave the power sector in the USA, focus on the core business in the UK and continue to adapt to tougher market conditions in the Czech Republic. Skanska’s Nordic construction units continue to deliver strong results. In Residential and Commercial Property Development the opportunities and growth ambitions remain. Due to a thin project pipeline in Europe Infrastructure Development will reduce the organization and mainly focus on the opportunities in the USA. Restructuring of the construction units will result in an impairment charge totaling SEK 1.0 billion, with no cash flow impact, and a restructuring cost amounting to SEK 100 M in the fourth quarter 2017. The unsatisfactory performance in the construction stream outside the Nordics during the fourth quarter of 2017 include write-downs amounting to a total of SEK 400 M, which relates to the construction operations in Skanska Poland. After the impairment charge, restructuring cost and project write-downs, the operating income for the full year 2017 is expected to be about SEK 5.3 billion and the earnings per share SEK 12. Operating income per business stream is expected as follows for the full year 2017    Jan-Dec One-offs Jan-Dec 2017 Jan 2017excl one (Impairment and incl one-offs -Dec -offs restructuring) 2016SEK billionOperatingincomeConstruction 2,1 -1,0 1,1 3,5Residential 1,7 1,7 1,6DevelopmentCommercial 2,7 2,7 2,3PropertyDevelopmentInfrastructure 0,9 0,9 1,8DevelopmentCentral and -1,0 -0,1 -1,1 -1,1eliminationsTotal 6,4 -1,1 5,3 8,2Earnings per 12 15,89share, SEK The restructuring process will continue this year and also encompass a review of Group Governance in order to reduce costs and increase organizational effectiveness. The charges related to these activities are estimated to be about SEK 600 M in 2018, and connected to lay-offs of about 3,000 employees. Cost savings from these lay-offs are expected to amount to about SEK 1 billion annually. Based on full-year financial results, Skanska’s Board of Directors proposes a maintained dividend of SEK 8.25 per share.                                              A telephone conference will be held at 9:00 am (CET), today Wednesday January 17. During the conference call, Skanska´s President and CEO Anders Danielsson and CFO Peter Wallin will describe the situation and respond to participants’ questions. To participate in the telephone conference, with the possibility to ask questions, please dial +46 8-505 564 74, or +44 20 3364 5374, or +1 855 753 2230. All other information related to the fourth quarter 2017, will be presented in Skanska’s year-end Report on February 1, 2018.

Changes in Skanska’s leadership team

Skanska announces a new Group Leadership Team working closer to the Business units in order to strengthen the units’ performance. A review of the Group Governance in order to reduce costs and increase organizational effectiveness has been initiated. The Group Leadership Team: Anders Danielsson, President and CEO The Construction Business Unit Presidents in the Nordics and Europe will report directly to Anders Danielsson. -       Worked at Skanska since 1991 Caroline Fellenius-Omnell, Executive Vice President, General Counsel -       Worked at Skanska since 2017 Richard Kennedy, Executive Vice President, responsibility for Skanska USA Construction and Skanska Infrastructure Development -       Previously Business Unit President Skanska USA Building -       Worked at Skanska since 2004 Claes Larsson, Executive Vice President, responsibility for Commercial Development globally, Residential Development Europe and BoKlok -       Worked at Skanska since 1990 Kirsi Mettälä, Executive Vice President, Human Resources -       Previously Senior Vice President Human Resources, Skanska Finland -       Worked at Skanska since 1994 Magnus Persson, Executive Vice President, Chief Financial Officer -       Previously Chief Financial Officer, Skanska Sweden -       Worked at Skanska since 2006 The Business Unit Presidents will be members of an Extended Leadership Team. Paul Hewins, today COO Skanska USA Building, succeeds Richard Kennedy as Business Unit President Skanska USA Building. Magnus Persson, today Executive Vice President Skanska Poland with responsibility for the Building operations, succeeds Piotr Janiszewski as Business Unit President Skanska Poland. All changes are effective as of today, January 17, with the exception of CFO Magnus Persson, who will take on his position as of February 2. Members of the former Executive team, Pierre Olofsson, Veronica Rörsgård, Peter Wallin and Christel Åkerman will leave Skanska. “I want to give a warm welcome to the members of the new Group Leadership Team. I am looking forward to work together to create a more profitable Skanska. I also want to extend a sincere thank you to Pierre Olofsson, Veronica Rörsgård, Christel Åkerman and Peter Wallin for all their hard work and their years in Skanska. They have all been key to developing Skanska to the highest international standard within their respective field”, said Anders Danielsson, President and CEO, Skanska. “I also want to thank Piotr Janiszewski for his many years with Skanska and welcome Paul Hewins and Magnus Persson to their new positions”, said Anders Danielsson. For more information and CV of the people in new positions visit www.skanska.com

Evolution launches world-first Live Texas Hold’em Bonus Poker with €50,000 Progressive Jackpot

Created in partnership with Games Marketing, Evolution’s Live Texas Hold’em Bonus Poker adds another exciting poker variant to the company’s extensive live table games portfolio. The new game, available on desktop, tablet and smartphone, offers a double bonus for players in the form of two optional side bets; Bonus Bet and First Five Progressive Jackpot. Both side bets offer separate extra chances to win alongside the main Texas Hold’em game, no matter what hand the dealer achieves. The optional Bonus Bet pays up to 1,000:1, while the First Five Progressive Jackpot side bet offers a progressively increasing top-level Jackpot prize for a Royal Flush. This same Jackpot side bet also gives players the chance to win lower fixed Jackpot prizes for a range of other poker hands. Todd Haushalter, Chief Product Officer at Evolution, commented: “The game is already well-established in the RNG and land-based casino worlds, so being the first and only live provider to offer Texas Hold’em Bonus is exciting for us. To add to the excitement, Evolution is funding a progressive jackpot that will start at €50,000. This is the first time we have ever launched a new game with a progressive jackpot on day one, so players will find a lot to like about the live version of Texas Hold’em Bonus.” Haushalter added: “We have invested intensively in poker games by securing the Live Casino rights to not just this game, but also Three Card Poker, Ultimate Texas Hold’em, Caribbean Stud, and Casino Hold’em. Different players like different games and we want to be sure that we can offer everything they could ever want to play and everything they might see in a land-based casino. In this way we are making the transition between land-based and online play — and vice versa — almost seamless.” Live Texas Hold’em Bonus Poker streams live from Evolution’s Riga studios. The game’s First Five Progressive Jackpot is available to Evolution licensees through an optional programme for this table. Those that sign up will have the optional Progressive Jackpot side bet enabled for their players.

Serial production initiated - SunCool factory in China to be inaugurated

The factory has a total area of 22,500m2 and consists of two factory buildings with an office building for up to 100 employees. Initially, the annual production capacity will be 1 million core tubes filled with SaltX patented energy storage material. A ramp up of the current, relatively low production rate, is anticipated within the coming months in order to meet an increasing market demand. "The start of serial production and inauguration of the SunCool factory mark an important milestone in the history of SaltX. We now have the large-scale manufacturing capabilities in place to meet the global market demand, both within and outside China”, says Karl Bohman, CEO of SaltX Technology. The inauguration is a two-day event and includes, in addition to the formal ceremony and dinner banquet, a factory tour with a preview of the production line. Click here to view a brief video clip with an interview with Karl Bohman. https://youtu.be/eoWamgVqXIU For more information, please contact:Karl Bohman, CEO SaltX Technology, tel: +46-705 600 268 About SunCoolThe SunCool collector produces and stores clean energy. It produces both heat and air-conditioning during day and night. Powered by the sun the SaltX material saves energy from the heat, and releases the energy when it is needed. This means twice as much energy can be delivered comnpared to a conventional solar collector. When adding the SunCool application to the solar panel system it will be possible to save up to EUR 100 per m2 installed. StockholmJanuary 17, 2018

Saab Inaugurates New Development Centre in Finland

For the first stage, Saab has established a unit at the STC with a focus on Electronic Warfare (EW). The unit contributes to deliveries for Saab´s current EW contracts for fighter aircraft, including Gripen E/F, the EW system for Airborne Early Warning & Control (AEW&C) aircraft, and the Electronic Support Measures/Electronic Intelligence systems (ESM/ELINT) used for land applications. During 2017, Saab recruited a number of engineers and invested in the establishment of the STC in Tampere, including a development laboratory. The recruitment and investment will continue in 2018. "Finland is a high-tech country and an important partner for Saab. The long-term goal is that STC in Tampere will be an integral part of Saab's product development and production," says Håkan Buskhe, Saab's President and CEO. “In February 2017, we established a comprehensive and long-term research partnership with Aalto University. As a natural continuation, we are now expanding the envelope from research to development of cutting-edge technology. In addition to job creation, this will also support export opportunities as part of Saab’s global business network,” says Anders Gardberg, Managing Director of Saab’s country unit Finland. The Saab Technology Centre concept is able to expand into other fields of activity and locations. Saab and its subsidiary Combitech Oy currently employ close to 100 employees in Finland, with offices in Helsinki, Espoo, Jyväskylä, Tampere and Säkylä. For further information, please contact: Saab Press Centre, +46 (0)734 180 018 presscentre@saabgroup.com www.saabgroup.com www.saabgroup.com/YouTube  Follow us on twitter: @saab  Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

RaySearch receives first order for the RayCare™ Oncology infomation System

Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, USA, has placed the first order for RayCare*, a next-generation oncology information system (OIS). RayCare is an innovative system designed to support comprehensive cancer care. It integrates seamlessly with the RayStation treatment planning system, but that’s just the start – RayCare will connect all the oncology disciplines, enabling users to fluidly coordinate tasks and ensure optimal use of resources.Over subsequent releases, RayCare will evolve into a machine learning OIS with unique capabilities to coordinate oncology tasks, supporting comprehensive cancer care organized around each patient’s needs. Many cancer patients receive a combination of treatment types, driving the need for combined workflows for radiation therapy, chemotherapy and surgery.ARCC decided to map out a future for their clinical workflows that would support advanced technology and data driven decision making. They determined that the best approach would be to move to a new treatment planning system and a new oncology information system that together would support their linacs and TomoTherapy systems, in order to have a unified platform for planning, treatment and assessment.Paul King, Chief Medical Physicist, says: “We evaluated all the leading systems and were extremely impressed by the possibilities of RayCare. It delivers on everything we were looking for. Getting all of these pieces integrated together will help us tremendously. RaySearch is an innovator with the leading technology in this area and I have great confidence in their ability to meet our needs into the future. We will keep exploring the cutting-edge of technology in order to secure the best possible care for our patients. RayCare will help us achieve this aim.”Dr. Scott Anderson, Radiation Oncologist and Medical Director, says: “We find ourselves in the position that we are at a decision point where we can stay static in a satisfactory status quo, or we can move into what will be the standard in the future. We look forward to working with RaySearch Laboratories to shape the future of longitudinal cancer care. Survivorship and tracking patients long term will be the benchmarks of cancer care moving forward. This new system that is being developed will give us better tools to do so.”Johan Löf, CEO of RaySearch, says: “I am delighted by this first RayCare order and very excited about helping ARCC achieve an efficient, integrated system for the future. RayCare is fundamentally different compared to other OIS systems, and we have invested a great deal of time and effort into creating something that will truly change the way that cancer is treated. Our goal is to advance cancer treatment with high-performance tools that combine treatment planning, workflow and data management, resource optimization, machine learning and follow-up in an effective way.”About Anderson Regional Cancer CenterAnderson Regional Cancer Center in Meridian, Mississippi, is a state-of-the-art cancer center equipped to provide innovative treatment for all types of cancer. The center sees about 180 outpatients a day for radiation or chemotherapy treatments and serves a geographical area across East Mississippi and West Alabama.About RayCareRayCare represents the future of OIS technology, developed from the ground up by RaySearch to support the complex logistical challenges of modern, large-scale radiation therapy centers. RayCare will integrate the high-performance radiation therapy algorithms available in RayStation with advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy.About RaySearchRaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company has now launched the next-generation oncology information system, RayCare*, which comprises a new product area for RaySearch. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.To learn more about RaySearch, go to: www.raysearchlabs.com* Subject to regulatory clearance in some markets. For further information, please contact:Johan Löf, President and CEO, RaySearch Laboratories AB (publ)Telephone: +46 (0)8-510 530 00johan.lof@raysearchlabs.com 

Loomis acquires KÖTTER Geld- & Wertdienste in Germany

Loomis has, through a wholly owned subsidiary, entered into an agreement to acquire 100 per cent of the limited partnership capital of KÖTTER Geld- und Wertdienste SE & Co. KG (“KGW”), which will be carved out from the KÖTTER group. KGW conducts domestic cash handling services and is based in Essen, Germany. The enterprise value, i.e. purchase price plus acquired net debt, is approximately EUR 14 million, corresponding to approximately SEK 140 million. KGW has approximately 800 employees and the annual revenue in 2017 is expected to be approximately EUR 45 million. The business will be reported in segment Europe and consolidated into Loomis as of closing of the transaction. The closing date is expected to be January 22, 2017. The purchase price is payable on closing. Due to acquisition related costs and integration costs the acquisition is expected to have a marginal negative impact on the earnings per share of Loomis in 2018. “With this acquisition Loomis expands into one of the biggest markets in Europe. In line with our overall strategy, the deal gives us the opportunity to take an active role in transforming both the German cash handling industry and the cash ecosystem in Germany. Under the leadership of the KÖTTER group, the company has become a quality service provider with great respect for both its employees and its customers. We aim to stay true to that and are glad to welcome all new employees and customers to the Loomis group” says Patrik Andersson, President and CEO of Loomis. January 17, 2018                                    

Loudspring acquires majority of Eagle Filters to save energy for energy companies

Loudspring Oyj Company release 18.01.2018, 08:30 (EEST) Loudspring has acquired a majority stake in Eagle Filters. With this acquisition Loudspring takes the first step towards becoming an operational company group saving natural resources. After the transaction Loudspring owns 63.4% of Eagle Filters, up from 34%.  The transactions includes investments of 300 000EUR into Eagle Filters as well as share swaps with the founders of Eagle Filters. After the transaction the amount of Loudspring’s class A shares will increase by 128 788 , which represent 0,5% of the outstanding shares after the transaction. The price per 1 Loudspring share is 2,64 in the share swap transaction. Agreements have been made with Eagle Filters and its current owners giving Loudspring the option to increase its ownership up to 80%.  Eagle Filters revenues in 2017 were appx 1.9 M€ (unaudited). Through adoption of Eagle products, the total saving potential for the energy industry is more than 10 billion USD, annually. The inclusion of Eagle Filters into Loudspring group is in line with the strategy update released in December, where Loudspring announced that it aims to consolidate a selection of its portfolio that are high growth, close to or already profitable and with low additional capital requirements. Eagle Filters fits these criteria. Eagle Filters brings with it access to top tier customers in the global energy industry where they enable significant fuel efficiency and CO2 savings. The company has an expanding product portfolio that includes high efficiency intake air filtration, intake air-cooling and cloud based software for real time monitoring of power plants. The products are in use in gas turbines and generating sets. Eagle is at a very interesting point in their growth where Eagle has proven its ability to save several million USD per power plant, and the products are currently being used in several installations by some of the largest utilities in the world, including Engie, the world’s largest gas turbine operator. Loudspring’s operational, marketing, business and growth expertise will now be a crucial component in attempting to accelerate growth for Eagle going forward. Eagle will continue to operate in the existing legal form under the Loudspring umbrella. Alexander Lidgren, CEO of Loudspring comments: “Loudspring is entering a new stage, where we transform into a company group focused on saving natural resources. As a first step we now have our own resource efficiency business for utilities. To target global leadership in carefully selected market pockets by consolidating portfolio companies into majority or fully-owned businesses is one of the goals outlined in our updated strategy, another is to turn one or more of our business units into high profitability and source of significant dividends.” Juha Kariluoto, CEO of Eagle Filters: “Loudspring’s increased holding and the financial injection into Eagle Filters  enable us to concentrate on our most important task we presently have – sales. Our products  have undeniably demonstrated their efficiency and reliability, we have recently had good order intake and now have the opportunity to grow rapidly. Also, recent repeat orders from IEC and Engie are good example of our customers’ trust on our technology and new orders from Asia and Europe reflect the interest in our story on energy savings we are able to generate to our customers.“ Lidgren continues: “Eagle is unique in its capability to achieve very large CO2 emission savings globally with easy to install solutions that have short pay-back times for utilities. We are extremely happy to have them be the first company consolidated into Loudspring and we look forward to accelerating it with our resources from our locations in Europe and in the United States.”

Episurf Medical receives market approval in Israel and signs distribution agreement for the Israeli market

Episurf Medical (NASDAQ: EPIS B) today announces that the Israeli Ministry of Health has approved Episurf Medical’s Episealer® knee products for the Israeli market. The approval follows a review process. Episurf Medical further announces that the company has entered into a distribution agreement for the Israeli market with AMI Technologies Ltd., a leading distributor of medical devices in Israel. “We are very happy to continue executing on our global strategy by opening up our first distribution market. This is an important step for Episurf Medical” says Pål Ryfors, CEO Episurf Medical.  For more  information, please contact: Pål Ryfors, CEO, Episurf Medical Tel:+46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com. This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.30 CET on 18 January 2018.

Alligator Bioscience appoints new VP Business Development

Lund, Sweden, 18 January – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today the appointment of Anu Balendran, PhD, as Vice President Business Development. Dr Balendran will be responsible for leading Alligator’s preclinical projects towards out-licensing. He has a PhD in Biochemistry and will join Alligator from his current role as External Innovation Director, AstraZeneca. He will assume his new role on 1 May 2018. This appointment follows those of Charlotte A Russell, MD, PhD, as Chief Medical Officer and Peter Ellmark, PhD, Associate Professor, as Vice President Discovery, in December 2017, as Alligator prepares a number of drug candidates for clinical studies, partnerships and licensing deals. “With three preclinical projects approaching clinical development and our business model to out-license projects after proof-of-concept in cancer patients, we are very pleased to make this important appointment to the management team. We look forward to welcoming Anu to Alligator. He brings extensive international experience in drug licensing and collaboration, complementing the growing team at Alligator”, said Per Norlén, CEO at Alligator Bioscience. For further information:Cecilia Hofvander, Director Investor Relations & CommunicationsPhone +46 46 286 44 95E-mail: cecilia.hofvander@alligatorbioscience.com. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 a.m. CET on 18 January 2018. About Alligator BioscienceAlligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s growing pipeline includes four lead clinical and pre-clinical drug candidates (ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527). ADC-1013 (JNJ-64457107) is licensed to Janssen Biotech, Inc., part of J&J, for global development and commercialization. Alligator’s shares are listed on Nasdaq Stockholm (ATORX). The Company is headquartered in Lund, Sweden, and has approximately 50 employees. For more information, please visit www.alligatorbioscience.com .